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Abstract 
Components of Medication Management:  Psychometric Properties of the Cognitive 
Screen for Medication Self-Management (CSMS) Test in Older Adults  
Darren M. Caffery 
Drexel University, Philadelphia, PA 
Mary V. Spiers, Ph.D. 
 
 
 
 
The Cognitive Screening for Medication Self-Management (CSMS) was developed to 
assess the sensory and cognitive constructs associated with medication adherence. It 
consists of various simulated tasks, designed to measure aspects of a medication 
regimen.  Tasks include bottle opening, label reading and telling time. In addition, it 
uses hypothetical medication taking regimens to assess prospective memory, 
encoding, recall, mental calculations, and executive/organizational strategies.  This 
study has several aims. First, it outlined the specific psychomotor, sensory and 
cognitive constructs involved in understanding and executing a medication regimen.  
Second, it integrated previous medication adherence research and pilot studies using 
the CSMS in evaluating aspects of content, construct, and criterion validity.  Third, 
using performance data of the CSMS scales from 60 older adults ranging in age from 
72-95, the discriminant and convergent construct validity of the CSMS scales was 
examined by a principal components analysis of the factor structure using a five-factor 
solution.  While the first two components were cognitive in nature, the third was 
comprised of both cognitive and non-cognitive elements.  The remaining components 
identified two distinct sensory components involving sensorimotor and visuosensory 
abilities.  Correlational analysis of CSMS performance scores with MMSE 
performance scores supported convergent relationships with global cognitive 
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functioning on tasks of retrospective and prospective memory, calculations, dose 
planning and processing speed, while discriminant relationships with tasks involving 
clock reading, bottle opening and label reading were demonstrated.  To further 
examine the construct validity, a number of subject group comparisons, using 
performance data from the CSMS scales were analyzed using univariate oneway 
ANOVAs to examine the effects of age and cognitive status on the medication taking 
tasks.  Cognitive status influenced performance on all the cognitive tasks except 
calculations.  Also, it did not influence clock reading or sensorimotor ability. Age 
influenced only two medication tasks which involved processing speed and 
prospective memory performance.  Lastly, this study examined the reliability (in terms 
of internal consistency), item difficulty and made recommendations for improving 
ecological validity.
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INTRODUCTION 
The future of neuropsychological assessment rests on the ability to develop tests 
that relate to specific behavioral and functional capacities.  In a clinical setting, 
practitioners often need assessment measures that are able to answer specific questions 
regarding the diagnosis and/or the functional capacities and limitations of those that 
they treat.  In addition, beyond the utility of the instrument, the effectiveness of the 
instrument and treatments which are based on its results rely on the reliability and 
validity of the measures being used. Neurobehavioral clinicians have a responsibility 
to use assessment measures which are developed in accordance with sound 
neuropsychological principles and those that have been proven to have adequate levels 
of reliability and validity. 
The concept of medication adherence is one which is very important to our 
health care system.  Balkrishnan (2005) reports that medication nonadherence in 
chronic conditions is a recognized public health problem. It is reported that 
individuals’ failure to adhere to their medication regimens costs the health care system 
of the United States as much as $300 billion annually.  As a result of both the 
individual and the larger systemic problems associated with medication nonadherence,  
Balkrishnan underscores the need to explore the effectiveness of various approaches 
aimed at improving medication adherence behaviors. 
Medication adherence is a complex and multifaceted concept which comprises a 
broad range of activities related to medication taking.  Medication non-adherence is 
manifested by individuals in a number of ways.  It can take a variety of forms 
including not having the prescription filled, taking an incorrect dose, taking the 
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medication at the wrong time, forgetting to take doses and termination of the 
medication too soon.  Individuals may also take the medications in the wrong 
combination or without following some special instructions associated with the 
medication (Park, 1992;  Gottlieb, 2000; Nichols-English & Poirer, 2000). 
Park & Jones (1997) reiterate the seriousness of nonadherence and cite an 
extensive body of literature to document this.  The difficulties related to medication 
adherence, obviously, are problematic to successfully treating the illness or symptoms 
that the medication was intended to alleviate.  These problems can further act as a 
catalyst for a host of other problems which may include increased visits to the hospital 
emergency room and synergistic interaction effects, such as dizziness and confusion.  
In extreme instances, problems with medication adherence could possibly lead to 
death.   Some research has estimated that problems resulting from nonadherence 
accounts for approximately 11.4% of hospitalizations in older persons (Fitten et. al., 
1995). 
Post-hoc adherence is often measured by a variety of strategies including pill 
counts, electronic vial caps, urine samples and clinical interviews.  All of these 
measures assist in determining if a patient is adhering to the prescribed medication 
regimen or not.  Although these measures are important, none of them assess a 
patient’s ability to understand and execute medication instructions before initiation of 
the regimen.  (Nichols-English & Poirer, 2000).  Thus, much of the research of 
involves the study of adherence after a medication program has gone into effect, and 
there is little information on assessing the cognitive and functional capacity to 
successfully adhere before the initiation of the treatment regimen.   
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Nichols-English & Poirer, (2000) differentiate between the concepts of 
medication adherence and compliance.  These authors suggest medication compliance 
originates from a practitioner centered paradigm which is more control oriented. 
Compliance relies more on patient obedience and can stigmatize a patient as engaging 
in deviant behavior if another course of action is chosen.  They describe adherence as 
a more interactive and collaborative relationship between the prescribing practitioner 
and the individual taking the medication. 
 Medication management has been considered an instrumental activity of daily 
living (Harvey & Jellinek, 1981) and Maddigan, et al. (2003) identify and define 
medication management capacity as another important aspect of adherence.  
According to them, medication management is the cognitive and functional ability to 
self-administer a medication regimen as it has been prescribed when it is the 
individual’s wish or desire to follow the regimen as prescribed.  Under the concept of 
medication management capacity, deviations from compliance are due to a lack of 
ability and are unintentional. These researchers report that in this way, medication 
management capacity differs from compliance or adherence.   
Measures of medication management capacity include functional skills such as 
correctly identifying medications, opening containers and selecting the proper dose 
and time of administration (MacLaughlin, et al., 2005).  The importance of medication 
management capacity is supported by research demonstrating that low medication 
management capacity is a predictor of greater emergency department utilization, 
functional decline and subsequent residence in assisted-living facilities (Edelberg et 
al., 2000). 
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In their review of adherence issues, Spiers & Kutzik (1998) present a framework 
which describes adherence as a process which requires successful management of the 
requisite behaviors of medication taking at a number of different stages.  The stages 
correspond to specific phases of the adherence process in the order of their logical 
progression and temporal sequence.  Each stage may include steps that correspond to 
actions related to task specific goals at each stage.  The logical and temporal sequence 
requires a progression by which the goals of each previous stage must be 
executed before it is possible to perform the goal related tasks of the next 
stage.  Included in this issue are any factors which compromise one’s ability to 
overcome obstacles in any given stage and would therefore prevent successful 
maintenance or completion of the entire process. 
 Unidimensional variables such as gender, race, education and age have proven 
to be inadequate as sole predictors (Sacket & Haynes, 1976; Kasl, 1975;  Spiers et al, 
2004) of medication adherence.  Studies also indicated that age (Balkrishnan, 1998), 
and memory ability (Spiers & Kutzik, 1995) although pertinent, are not independent 
and reliable predictors for medication adherence and medication taking.   Thus, much 
of the research in this area of study seems to confirm that the predictors of medication 
adherence are complex and interactive (Murray et al., 2004) and often difficult to 
observe outside the laboratory setting. 
Medication Adherence in Older Adults 
Medication adherence is especially a problem for older adults.  This group 
consumes the greatest proportion of prescription medications in the country, and has a 
history of average rates of medication nonadherence as high as 55% (Sackett & Snow, 
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1979;  Buckalew & Sallos, 1986;  Nichols-English & Poirier, 2000;  ).  Spiers & 
Kutzik (1998) highlight two common types of problems experienced in this population 
to illustrate the utility of their framework of medication taking and adherence.  
Since many older adults often need to manage medications over the long term or 
for the rest of their life, one of the problems highlighted by Spiers & Kutzik (1998), 
involves obstacles to successful long term medication self-management.  The issue of 
one’s ability to understand their own medication routine is one that appears to be 
fundamental, but multi-factorial, and further confounded by the interdependence of 
additional factors associated with it.  
A number of studies (Levy & Loftus, 1993; Spiers & Kutzik, 1998) also confirm 
previous research in identifying the complexity of the medication routine and the 
number of medications as relevant factors in how successful older adults are in 
understanding and following a medication routine.  It was previously estimated that 75 
percent of the population over age 65 took at least one prescription medication 
(Helling et al., 1986; Hanlon et al., 1992).  Previous studies have reported the average 
number of medications for those over age 65 ranged between two and four (Hanlon et 
al., 1992) however a more recent study (Miller, 2003) cites four to five medications as 
typical for this aged population.  Increased  numbers of medications being taken, the 
complexity of the overall regimen, in addition to possible declining cognitive function 
suggest that cognitive factors indeed play a significant role in the ability of the elderly 
to take their medications successfully (Maddigan et al, 2003). 
The other fundamental problem regarding medication adherence identified by 
Spiers and Kutzik (1998) is associated with the comprehension of instructions.  This 
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includes the difficulties associated with translating the required medication 
instructions into the appropriate actions of adherence.  One study reported that 40% to 
60% of patients could not correctly report what their physicians expected of them less 
than 90 minutes after they were provided with the information (Svarstad, 1976).   Yet 
another study reported that over 60% of the patients interviewed immediately after the 
visit with their doctors had misunderstood the directions regarding prescribed 
medications (Boyd, et al., 1976).  For these elderly patients, medication issues and/or 
abuses may also result in accidents, such as falls or concussions (Cooper et al., 1982).  
Furthermore, an elderly patient could potentially forget that he or she had already 
taken the prescribed amount of medication and mistakenly overdose. Although these 
errors are rare, they are quite serious. 
One of the reasons that problems of adherence may be such a prevalent issue 
with older adults involves the aging process and associated cognitive decline.  
Cognitive impairment is an important factor in predicting poor medication adherence 
and there is certainly a multitude of previous research studies which support this 
(Meyer & Schuna, 1989; Isaac & Tamblyn, 1993; Gurland et al.,1994; Fitten et al., 
1995; Ruscin & Selma, 1996; Edelberg et al., 1999;  Okuno, 2001).  Although the 
range of cognitive variation is known to be quite wide, age-related cognitive 
difficulties are a well documented phenomenon and typically observed as a 
generalized slowing of information processing ability (Salthouse, 1991).   
Since cognitive deficits have been shown to impose detrimental effects on the 
medication management process, clinical observations of poor understanding in older 
adults has lead researchers to study some of the associated functional and cognitive 
 7
substrates.   Even the most basic medication routine can become problematic when the 
requisite cognitive sub skills needed to carry out the routine are compromised.  
Previous studies (Park, 1994;  Maddigan et al, 2003) highlight a number of interrelated 
factors which appear to be most relevant to the medication management process.  
These include psychomotor and sensory/perceptual skills, comprehension, memory 
ability and executive/organizational abilities. 
Although these and other previous studies have been important in outlining some 
of the functional skills and substrates associated with medication taking, none provide 
an integrative theoretical framework which clearly delineate and relate the specific 
individual motor, sensory and cognitive constructs of medication taking behavior in a 
comprehensive manner. 
Development of the Cognitive Screening for Medication Self-Management 
The increased probability of cognitive impairment with advancing age and the 
increased use of medications certainly puts older adults at risk for poor adherence.  
Therefore an important step in facilitating successful adherence to a medication 
regimen is to identify individuals at risk for inability to manage their medication 
regimen as a result of cognitive difficulties. 
Some of the research related to medication taking and cognitive impairment has 
used general screening indices of cognitive function or other standardized cognitive 
assessment devices. These commonly used screening measures include the Mini 
Mental Status Examination also known as the MMSE (Folstein, Folstein & McHugh, 
1975) and the Neurobehavioral Cognitive Status Examination, also known as the 
NCSE or Cognistat (Marcotte et al, 1997).  Although the MMSE is a commonly used 
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screening device to assess general cognitive function, one study found that 40% to 
80% of older adults were observed to have impaired executive cognitive function 
despite having MMSE scores which did not indicate such impairment (Royall et al., 
2000).   
Aside from the general screening tests of cognitive ability, there are also a 
number of screening tests which assess specific elements associated with medication 
taking and which may help evaluate older patients’ medication management skills.  A 
number of assessment tools utilize questions and tasks which involve the actual or 
“real life” medication regimens of those taking the test.  The MedTake test (Raehl, et 
al, 2002) is an assessment instrument which utilizes questions about the examinees’ 
‘real life’ medication regimen.  The MedTake test asks older adults to describe how 
they take each of their oral prescription medications.  Resulting data from the use of 
this instrument clearly indicates a general cognitive component of medication taking 
as performance on the test was significantly related to performance on the MMSE (r = 
.50, p = .002).  In addition, the research involving the MedTake test supports evidence 
of predictive validity as poor scores were associated with the need for Medicaid 
assistance within 10 years. 
A study by Edelberg, Shallenberger, and Wei (1999) describes an instrument 
called the Drug Regimen Unassisted Grading Scale (DRUGS).  The DRUGS tool is 
another screening tool that utilizes questions and tasks regarding an actual medication 
regimen.  The DRUGS tool evaluates patients’ ability to identify their own 
medication, open the container, remove the appropriate dosage and demonstrate the 
appropriate timing of each of their own prescription and over the counter medications.  
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In a study of 60 older outpatients, these researchers found that patients’ scores were 
inversely related to age and were significantly lower in those residing in an assisted 
living environment when compared to those that live at home.  Results from a 12-
month follow-up study conducted by Edelberg et al (2000), indicated that a move from 
independent living to an assisted living facility was associated with a significant 
decline in the DRUGS score. 
A number of screening tools also utilize simulated tasks of medication 
management.  Meyer and Schuna, (1989), described the use of their screening tool in 
93 patients from inpatient and outpatient settings.  Components of this tool included 
patient self-report of medication management in addition to the simulated ability to 
read labels, open containers, understand the requirements of taking medications 
according to a three time daily regimen, remove tablets and to differentiate colors.  
Ruscin and Semla (1996), later adapted the tool described by Meyer and Schuna and 
in their study of 83 outpatients, they found that having at least one physical 
dependency in activities of daily living or cognitive impairment (as measured by a 
score of <24 on the MMSE) was an independent risk factor for poor performance on 
the test. 
Gurland et. al (1994) outlined the development of a Medication Management 
Test (MMT).  The MMT was described as a performance test of adaptive functioning 
which also used a series of simulated tasks associated with the self-administration of 
medications.  The tasks outlined in this study included the learning and recall of a 
number of pills in a medication bottle over three trials, demonstrating the subtraction 
of three pills from the nine in the medication bottle, calculating how long the pills 
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would last on a given regimen, working out the days for taking pills on a stipulated 
regimen covering a two week period (with and without prompting over two trials), and 
picking out the key medication bottle (designated by a previously learned therapeutic 
purpose of the pills it contains, and by prompted descriptors of the medication bottle, 
if necessary).  In addition, this assessment measure also included tasks such as 
following instructions to remove three pills, then replace and return the key 
medication bottle to its correct place, selecting the key medication bottle and removing 
the specified number of pills on a delayed signal (with and without prompting) and 
describing to a third party, the distinguishing features of the key medication bottle 
designated by its therapeutic use.   
The MMT was specifically developed to detect early and mild dementia and was 
found useful in differentiating dementia from normal aging.  A future study using the 
MMT found the test related to neuropsychological status and HIV medication 
adherence (Albert et. al, 1999).  Unfortunately, no normative data was provided and in 
addition, like much of the other research in this area of study, little consideration was 
given to describing the specific cognitive substrates associated with the medication 
taking process. 
Research by Fitten et al. (1995) described an adherence capability instrument 
called the Regimen Adherence Capacity Test (RACT) which evaluated cognitive and 
functional abilities.  Functional capacity was assessed by tasks of manual dexterity, 
ability to read and comprehend prescription labels and understanding of two 
hypothetical medication regimens.  In their comparison between medically ill 
inpatients and outpatients, and an aged matched control group, they found that the 
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medically ill patients failed the hypothetical scenarios more often than controls (29% 
vs 5%).  This study found no difference between the groups on manual dexterity and 
the ability to read and comprehend prescription labels. In addition, there was also a 
moderate to good correlation observed between MMSE scores and performance on 
each scenario (r = .7 and r = .69; p <.01 for scenarios 1 and 2, respectively) which 
supported the identification of a general cognitive functioning as a construct related to  
medication management capabilities. 
In another study which supported evidence for the cognitive component of 
medication management, Patterson, et al., (2002) used a modification of the 
Medication Management Test and called their adapted tool the Medication 
Management Ability Assessment (MMAA).  In a comparative study of older 
schizophrenic outpatients and normal controls, they found the outpatients performed 
more poorly on their medication task.  In addition, worse performance on their 
measure was also related to more severe negative symptoms of the disease and to 
greater cognitive impairment as measured by the MMSE.  Again, there was little 
consideration given to describing the specific cognitive substrates associated with 
medication taking. 
Although the MMSE is a quick and gross measure of general cognitive ability 
and much of the previous research regarding medication management has supported 
its ability to identify a relationship with medication taking ability, it lacks the 
specificity to encompass all of the tasks associated with medication taking.  In 
addition, the MMSE also lacks the sensitivity to capture the age-related cognitive 
changes that may also affect medication taking ability (Raehl, et al, 2006).   
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Matarazzo (1992) and Ardila et al. (1998) have emphasized the necessity of a 
better understanding of the structure of cognitive activity and the analysis of the 
component processes underlying cognitive function as measured by our 
neuropsychological tests.  As a result of the need for a medication management 
assessment tool which integrates all of the individual and specific motor, sensory and 
neurocognitive processes which are associated with medication taking, the Cognitive 
Screening for Medication Self-Management (CSMS), was developed and introduced 
by Spiers (1994). 
Substrates of Medication Management 
The CSMS was constructed using 13 simulated tasks which are believed to 
assess the specific individual sensory, motor and cognitive processes that are required 
for successful medication management and adherence in the elderly.  Previous and 
current research using the CSMS is beginning to comprehensively identify, describe 
and integrate a number of sensory, motor and cognitive substrates which appear to be 
required for medication taking. 
  Sensorimotor Ability.  The CSMS requires participants to physically open three 
types of medication containers.  These include a small flip top container, a small child 
resistant container and a medium screw top vial. 
A person who is taking medications must have adequate manual dexterity and 
must be able to open various types of medication containers.  A number of previously 
described assessment tools involving medication management include container and 
bottle opening tasks (Meyer & Schuna, 1989;  Spiers, 1994;  Fitten et al., 1995;  
Edelberg et al., 2000) and the inability to open a prescription medication vial has been 
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shown to be a factor associated with medication nonadherence (Murray et al., 1986). 
Many older adults suffer from some degree of osteoarthritis and as a result, may 
experience limited hand strength and difficulty manipulating their fingers which can 
make opening certain types of medication containers very problematic (Park & Jones, 
1997).  A number of studies have confirmed that older persons especially have 
difficulty with this type of task (Hurd & Butkovich, 1986;  Murray et al., 1986;  Meyer 
& Schuna. 1989).  A study by Ruscin and Semla (1996) using a medication container 
opening task with a sample of older adults supports the criterion-related and construct 
validity of this type of medication management task.  Their research described the 
predictive ability of this task in identifying those who need help with activities of daily 
living at home.  In addition to supporting evidence of predictive and convergent 
validity, the results of their study also support the discriminant validity of this type of 
task.  They identified impaired cognition and physical dependency (inability to open 
medication vials) as two factors which were independently associated with poor 
medication management skills.  Meyer and Shuna (1989) add further support of the 
discriminant validity of this task.  Their research also demonstrated the ability to open 
medication containers to be independent of cognition. As a result, detection of those at 
risk for problems with medication management can be assisted, not only by assessing 
various cognitive abilities, but also by assessing the sensory and motor ability required 
to open prescription medication vials. 
  Visuosensory Ability.  The CSMS involves tasks of reading and visual acuity as 
it requires participants to be able to read information on medication labels of various 
font sizes.   In addition, since those who take medication sometimes have multiple 
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prescriptions, the CSMS also requires participants to differentiate between various 
tablet colors.  
At the visuosensory level, a person taking medications must have adequate 
visual acuity and must be able to read the information presented on a medication label.  
A number of previously described assessment tools involving medication management 
also include tasks which require the ability to read information on a prescription 
medication label (Meyer & Schuna, 1989;  Spiers, 1994;  Fitten et al., 1995;  Edelberg 
et al., 2000).  Inability to read prescription labels is another factor associated with 
medication nonadherence (Murray et al., 1986). 
Another visuosensory ability associated with medication management involves 
the ability to differentiate between pill tablets of different colors.  Hurd and Blevins, 
(1984) reported that the lens of the eye tends to yellow with age which leads to 
problems with glare, decreased acuity and poor color differentiation.  A number of 
studies confirm that older adults have difficulty with tasks of label reading and tablet 
color differentiation (Meyer & Schuna. 1989).  Some studies also support poor label 
reading ability as another factor in predicting nonadherence (Hurd & Butkovich, 1986;  
Murray et al., 1986). 
  Clock Reading/Telling Time. Interestingly, of all the medication management 
assessment tools which were reviewed, only the CSMS includes a clock reading task.  
With a number of stimulus clocks that include hands in all four quadrants, the CSMS 
clock reading task was designed to also be used as screening measure for visual 
neglect and inattention. 
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Telling time or clock recognition is another measure involving visuoperceptual 
ability (Hill et al., 1995).  Clock reading involves a semantic conceptual component 
that seems to be associated with comprehension of time concepts in addition to the 
processing of overlearned visuospatial and numerical information.  It can also be 
conceptualized as a type of visual associative knowledge which is dependent on the 
interaction between perceptual processes and semantic memory, mediated by visual 
information processing circuits in the brain (Fahlander, 2002). Clock reading is 
construed as an everyday life task which is likely to be highly automatized in most 
adults (Schmidtke & Hull, 2002;  Bodner, et al., 2004).   
  Calculational Ability.  Another component of medication management involves 
the ability to understand and process dosage calculations (Meyer & Schuna, 1989; 
Spiers, 1994; Fitten et al., 1995;  Edelberg et al., 2000).  The CSMS involves a task 
which requires the processing of dosage calculations.  It is comprised of two dose 
calculation items.  The first involves basic addition while the second is a bit more 
challenging and involves addition and simple division. 
  Calculational ability seems to represent a rather complex and multi-factorial 
cognitive ability related to orthographic knowledge, mathematical ability, and is 
dependent on verbal, visuoperceptual, visuospatial and attentional/memory abilities 
(Ardila, et al., 1998).  Calculation tasks often include the assessment of arithmetic 
facts knowledge, complex mental calculation and written calculation. The term 
arithmetic “facts” commonly refers to those problems (addition, subtraction, 
multiplication and possibly division) in which the solution does not require further 
computational processes or strategies (e.g., 3x4, 5+3, 10-4).  Arithmetic facts are 
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believed to be stored in long term memory and to be retrieved from there as other 
semantic knowledge (Delazer, et al., 2003). 
  A theoretical model of calculational abilities proposed by McCloskey (1992) 
draws major distinction between the numerical processing system, including the 
cognitive mechanisms mediating comprehension and production of Arabic and verbal 
numerals, and the calculational system comprising functionally independent 
components dedicated to simple arithmetic fact retrieval to the processing of 
arithmetic signs and to complex calculational procedures.  Within the numerical 
system, further distinctions can also be made between the numerical comprehension 
system and the numeral productions system.  Within these systems, further 
distinctions can be made between different codes , such as spoken number words, 
written number words, or Arabic numerals, and between different numerical 
information  such as lexical processing and syntactic processing. 
  Another model proposed by Dehaene & Cohen (1995), suggests a modular 
cognitive structure of calculational ability based on the existence of three different 
numerical representations, the auditory verbal code, the visual number form and the 
analog magnitude representation.  Different numerical tasks are thought to rely 
specifically on one of these codes.  The analog magnitude representation supports 
number comparison, subitizing, estimation and approximate calculation while the 
auditory verbal code mediates counting, overlearned arithmetic facts (which include 
multiplication and some addition problems) and verbal input and output processes.  
The visual number form is active in multi-digit operations, parity judgments and in 
input and output processes involving Arabic numerals. Therefore, while the 
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McCloskey model focuses on numerical transcoding and calculation, the Dehaene and 
Cohen model considers a wider range of numerical abilities. 
Although none of the previously reviewed assessment measures of medication 
management explicitly describe a working model of a calculational cognitive substrate 
in terms of their construct validity, research involving a similar and previously well 
validated task, may begin to assist in more clearly operationalizing this construct.   
The arithmetic subtest of the Wechsler Intelligence Scale-III (Wechsler, 1997) 
is one such task which may be very similar to the dosage calculational skills often 
involved in a medication management process.  The arithmetic subtest involves the 
ability to understand and process mental mathematical calculations.  Research 
involving the factor structure of the WAIS-III battery has shown that the arithmetic 
subtest is related to both a verbal comprehension construct and a working memory 
construct.  This relationship is also suggested in other studies which found 
relationships between mathematics disability and reading disability (Gillis et al., 1992;  
Light & DeFries, 1995).   
Evidence of the convergent construct validity of the WAIS-III battery is 
supported by significant intercorrelations between the arithmetic subtest and a number 
of related subtests which involve verbal comprehension, remote memory of 
overlearned factual information and attentional ability or “freedom from 
distractibility”.  As a result, performance on the arithmetic subtest loads into factors of 
general cognitive/intellectual ability and verbal cognitive ability, in addition to two 
specific indices which appear to measure verbal comprehension and working memory.  
Within the working memory factor construct of this battery, the arithmetic subtest 
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score was found to be significantly correlated with scores from both the digit span 
subtest and the letter-number sequencing subtest. 
  In the technical manual for the WAIS-III, Wechsler (1997) details how the 
concept of working memory has replaced or at least, updated the concept of short term 
memory.   Within this theoretical framework, the conceptual workspace is viewed as 
an active part of the information processing system as opposed to the traditional short-
term memory which was viewed as the passive storage buffer.  Therefore the concepts 
of working memory and short-term memory are similar because both refer to the 
temporary storage of incoming information and because both are limited in capacity.  
Whereas short-term memory is viewed as a passive form of memory, working memory 
is construed as more of an active form.  Traditional short-term memory refers to the 
passive storage of information while that information either becomes encoded into 
long-term memory or is forgotten.  Working memory, however, serves as more than a 
temporary storage space for incoming information.  It can be construed as the 
“cognitive workspace” where calculations and manipulations processes occur.   
  De Jonge and de Jong (1996) categorized two types of working memory tasks 
by complexity.  Simple span tasks such as the digit span (forward) subtest from the 
WAIS-III measure the storage component of working memory because they 
deemphasize the manipulation of the material.  Complex span tasks involve both the 
simultaneous storage and processing of information where an examinee must perform 
two different types of mental processes at the same time.  A working memory task 
becomes complex by increasing the amount of material that must be manipulated.   
Despite the distinctions between simple and complex tasks, the research has shown 
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that these types of working memory tasks are related and that both form a single 
dimension.  
Research by Salthouse and Coon (1994) suggests that age is more likely to 
affect more complex non-retrieval arithmetical processes by declines in processing 
speed.  However, for arithmetic skills which appear to rely more on basic arithmetic 
retrieval processes, calculational ability is often spared.  This may be a result of older 
adults’ ability to compensate for age related decrements in retrieval due to a higher 
level of arithmetic skills which were acquired during elementary school (Geary & 
Linn, 1998). 
  Organization, Encoding and Recall.  The Prescription Memory Test of the 
CSMS includes a number of subtests which involve the organization, encoding and 
recall of hypothetical medication information. 
The process by which information is transformed into mental representations 
before either temporary or long-term storage is called encoding (Atkinson & Shiffrin, 
1968).  The process of encoding typically involves a number of overt and covert 
information processing activities which facilitate the acquisition, storage and 
subsequent retrieval of information to be learned (Kardash & Amlund, 1991).  Warr 
and Allan (1998) have drawn on previous conceptual and empirical research to 
suggest three types of declarative-knowledge learning strategies that can be used.  
These cognitive learning strategies consist of rehearsal, organization and elaboration.   
The rehearsal process includes procedures to repeat the information being 
learned.  This process does not involve reflecting about the meaning of the material, 
changing it, or seeing how it fits in with other material already stored.  Central to this 
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process is mental repetition.  With regards to visually presented material, it may 
involve copying of the visual information in the form it is presented.  Rehearsal 
illustrates a “surface approach to learning rather than a meaning orientation 
(Richardson, 1990).  It is often viewed as emphasizing performance rather than 
intellectual mastery of a subject which is addressed by the next two strategies (Fisher 
and Ford, 1998). 
Warr and Allan (1998) describe organization strategies as procedures to 
identify key issues and create mental structures which group, interrelate or “chunk” 
elements to be learned.  This process extends beyond the simplistic nature of rehearsal 
and involves the active imposition of some organization (either verbal or visual) of the 
material to be learned.  They describe elaboration strategies as procedures to examine 
implications and to make connections between material to be learned and existing 
knowledge. This process extends organization in that it seeks to increase 
understanding by changing the way material is viewed in the context of other 
information.  These learning strategies are widely viewed as varying within, as well as 
between individuals and the general assumption is that principal strategies are 
positively associated with effective learning. 
There is adequate evidence that reveals encoding is most impaired with age 
when the tasks demand self-initiated processing and there are relatively few cues or 
environmental supports to guide the encoding (Craik, 1986; Park, et al., 1990).  As a 
result, the problems associated with self-initiated activities and the effectiveness of 
organizational strategies appear to be an important underlying mechanisms which 
influence older adults’ performance on cognitive tests involving memory and recall 
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(Lamar, et al, 1998).  It is well documented that age-related memory decline is related 
to deficits in the ability to simultaneously store and process information (Salthouse, 
1991).  These difficulties may contribute to problems in organizing complex medical 
information which often results in poor comprehension of a medication regimen (Park, 
1992). 
The research involving organizational strategies historically supports this.  
Park et al. (1990) reported large age differences when old and young adults 
intentionally encoded pairs of unrelated pictures, but much smaller differences when 
the pictures were related.  Smith et al. (1998) found that elderly individuals integrate a 
target with a contextual cue more effectively if there is a preexisting relationship 
between target and cue or an integration which is provided by the experimenter.  
These results confirm that the elderly seem to encounter difficulties with integration 
when the parts are seemingly unrelated and they must engage in self-initiated 
processing, which draws more heavily on cognitive resources.   
   A study by Morrow et al. (1991) which integrated organizational and medication 
planning strategies provides useful information regarding how older adults encode and 
process medication related information.  This research involved an assessment of how 
older adults organized information necessary to understand specific prescription 
medications and was pertinent in assessing the influence of such organization on 
future recall.  These researchers tested subjects’ recall with the different types of 
organizational schemas produced to assess the effectiveness of the utilized 
organizational strategies.  In this study, experimenters asked subjects to perform two 
types of tasks; One was a organizational task where the subjects were asked to sort ten 
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pieces of specific medication information into categories of similarity while the other 
was an order oriented task which asked the subjects to arrange the ten individual 
pieces of medication information into an order that they deemed an effective set of 
instructions.  The ten bits of medication information, which were individually noted 
on index cards included:  medication name;  physician name and phone number; 
purpose of medication;  dose;  schedule;  duration;  warnings; mild side effects;  
severe side effects; emergency/911 information.  Subjects were administered both 
tasks.  When the order task was analyzed according to hierarchical cluster solutions, 
three schemas emerged which were identified as general information, how to take and 
possible outcomes. 
Another experiment in this study allowed subjects to study the medication 
information under one of three organizational methods.  These three methods included 
a standard structure method (using the three identified schemas organized and ordered 
exactly as in the prior experiment), a scrambled structure method (using instructions in 
a non-preferred order), and a category structure method (using the three schemas but 
not in the correct order as arranged in the previous experiment).  The results suggest 
that memory for medication instructions are influenced by both the format and the 
type of the instructions.  Recall of the medication information increased as the 
compatibility of the instructions to the schemas created in the prior experiment 
increased.    
Lamar (1996) compared the ability to organize prescription information on the 
CSMS among adults over age 80, using different instructional types., One 
“experimenter-imposed” (EI) instruction group was given specific guidelines to 
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facilitate organization of the prescription information while a subject imposed (SI) 
instruction group was left to organize the information in any manner they wanted.  
After an organization and study phase of the prescription information, the subjects 
were tested on immediate and free recall measures.  The IE group was shown to 
produce more semantic clusters and also performed better on the recall tasks.  Thus, 
those using better organizational strategies showed increased clustering and better 
recall.   
Another study by Morrow et al. (1993) furthered research in this area and 
compared performance of younger and older adults.  The results of that study found 
that older adults do not remember structured medication instructions as well as 
younger adults.  The results of these age comparisons and the previous mentioned 
studies involving the organization of medication information supports the idea that the 
recall problem that older adults experience when forced to initiate their own 
organizational strategy is a result of their difficulty or inability to create categories 
which are cohesive or well-related. 
In addition to tasks involving encoding, the Prescription Memory Task of the 
CSMS also involves various tasks involving retrospective memory including 
immediate and delayed free recall tasks and a cued recall task.  Declines in long-term 
memory and recall may affect older adults’ ability to remember what they are to do 
with a medication plan once they have developed one (Park & Jones, 1997).  Kutzik 
and colleagues (1991) reported that “forgetting” was implicated in 23% of instances of 
self-reported nonadherence.  In alignment with Spiers and Kutzik (1995), this current 
research supports the idea that determining the role of memory in adherence to 
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prescription regimens among the elderly is essential to understanding the specific 
cognitive components of medication self-management in that population.   
Park et al. (1996) found that individual differences in speed and working 
memory accounted for age-related variance on many types of long-term memory tasks 
including free recall and cued recall.  One broad theory attributes memory decline to a 
decline in processing resources which limits the ability to encode and retrieve 
information.  Craik & Byrd (1982) argued that age related declines in memory were 
caused by decreased “mental energy” or processing resources which limited the ability 
of older adults to engage in self-initiated processing.  Later theorists suggested that the 
empirical measurement of processing resource could be represented by the speed of 
information processing (Salthouse, 1996) or working memory capacity (Park et al, 
1996), both of which decline with age.  Studies have conclusively demonstrated that 
both speed of processing and working memory mediate most, if not all age-related 
variance in long term-memory (Park & Gutchess, 2004).  These findings certainly 
demonstrate the utility of these constructs in furthering the understanding long-term 
memory. 
A study conducted by Price et al, (1998) using a sample of healthy older adults 
investigated the age-related differences believed to be involved in learning and 
recalling information from a new medication sequence.   In this study, the Prescription 
Memory Test (PMT) from the CSMS and the CVLT-9 (Libon, et al, 1996) were used 
to assess learning and memory performance while the Mini-Mental Status Exam 
(Folstein, Folstein & McHugh, 1975) was used to screen for normal general cognitive 
ability.  The researchers used the following age categorizations (as outlined in Moody, 
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1998) to group their participants: “young-old” was used to classify participants from 
ages 65-74; “old-old” for ages 75 -84; and “oldest-old” for ages 85 and over.  In their 
generally healthy, normal sample of older adults, the young-old participants recalled 
significantly more prescription medication information than those participants in the 
other two age groups. Interestingly, when provided with a content cue, the difference 
in cognitive performance was eliminated.  These results suggested that all age groups 
were encoding the information and that age related differences could be compensated 
for when a structured stimulus cue was provided.  Similar changes in memory 
performance were also observed on the CVLT-9.  Since the CVLT-9 has been 
previously established as a neuropsychologically validated memory test, the results of 
this study lend support for the concurrent criterion related validity of the CSMS as a 
measure of memory ability.  These theory-consistent findings involving age-related 
memory performance and decline, and the benefit of external strategies such as cueing 
also lend support to the construct validity of the CSMS.  These findings serve as 
preliminary evidence to support the idea that tasks measuring the cognitive 
components of medication learning and recall are performed in a similar manner 
across age groups of healthy adults. 
Another study (Lamar et al, 1998) using the Prescription Memory Test subtest of 
the CSMS was conducted to assess the accuracy of the CSMS memory task in 
discriminating groups of older adults based on their age and overall cognitive 
functioning.  These researchers predicted that select indices of the Prescription 
Memory Test (PMT) would classify patients according to their overall level of 
cognitive function and age classification (e.g. young-old, old-old, oldest-old). Using 
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the MMSE as a criterion to assess cognitive function and the CVLT-9 as another 
measure to assess learning/memory, the results of this study demonstrated the PMT to 
be more sensitive than the CVLT-9 in distinguishing the impaired from the 
unimpaired elderly. In addition, the PMT also demonstrated a stronger relationship 
with increasing age than the CVLT-9.   
The study of Lamar et al. (1998) also supports various forms of validity of the 
CSMS.  The results and relationship of the Prescription Memory Test of the CSMS 
and the more well- established CVLT-9 measure support the convergent construct 
validity and criterion related validity of the CSMS.   The Prescription Memory Test of 
the CSMS was shown to involve an assessment of memory and in addition, it also 
discriminated cognitive status better than a previously established and validated 
measure of memory assessment. In addition, the ecological validity of the CSMS task 
was also supported.  Performance on the Prescription Memory task of the CSMS was 
shown to be clearly related to an everyday skill which has specific relevance in the 
aging population.   
  Processing Speed.  The CSMS Prescription Memory Test involves a task which 
appears to assess processing speed.  In one of the tasks involving the organization and 
arrangement of hypothetical medication information, two scores involving processing 
speed are recorded. One score involves the amount of time it takes the participant to 
arrange the information cards while another involves the amount of time the 
participant uses to study the information before they are asked to recall it. 
Nebes et al. (2000) identifies processing speed as another cognitive process 
which is relevant to the construct of working memory described by Baddeley (1996). 
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According to Kail and Salthouse (1994), processing speed is the maximum rate at 
which basic cognitive operations can be executed.  They construe it as a general 
purpose resource in that the rate of processing can place limits performance on higher 
level operations.  Many higher order processes such as comprehension of a medication 
routine require simultaneous access to multiple sources of information.  If processing 
is too slow, not all information may be available at the time it is needed and therefore 
the subject may be forced to re-activate information or repeat the processing steps.   
Kail and Salthouse (1994) also find it important to note that the effect of 
processing speed on performance is based on the internal dynamics of the processing 
system, not just the time required to complete the task.  Salthouse (1992; 1996) 
suggests that age decrements in working memory capacity also arise in part, from a 
slowing of cognitive processing, whereas in the model of working memory, the 
amount of information that can be held in working memory is partly determined by the 
speed in which it can be refreshed through rehearsal (Baddeley, 1996).  Therefore, this 
generalized slowing of information processing is also identified as another factor 
which is often associated with age-related cognitive decline. 
  Prospective Memory.  The CSMS Prospective Memory Task was designed to 
first have the medication user repeat and indicate understanding of to-be-remembered 
instructions about a medication.  Then, upon a future behavioral cue from the 
examiner, the participant is expected to carry out the instruction by taking a pill out of 
a medication container upon recognition of the cue.  While the former component of 
this task is believed to involve encoding, the latter component represents the 
recognition and execution of the required intention behavior. 
 28
Park & Jones (1997) identify prospective memory as one type of memory which 
has a critical impact on medication adherence. Prospective memory ability involves 
remembering to perform planned actions in the future.  Remembering to take a 
medication at the appropriate time is an example of a prospective memory ability.  
Prospective memory, when associated with a contextual cue or event (such as taking a 
medication with breakfast) does not appear to decline as much with age when 
compared to prospective memory that is time based. Time-based prospective memory 
requires a response that must occur at a specific time, and is not cued by an event. 
Park & Kidder (1996) believe that the retrospective aspects of medication taking 
which include understanding and remembering the regimen may influence individuals’ 
prospective performance with respect to medication taking.  Because of the time based 
nature of medication adherence, the prospective memory aspect of adherence may be a 
particularly difficult task for older adults.  These researchers also believe however, 
that this difficulty can be compensated for, to some extent, by associating the time 
based task to an event.  
Multicomponent models of prospective memory suggest that the realization of 
delayed intentions is supported by prospective and retrospective components 
responsible for the recognition that some intention is to be realized and the recovery of 
the relevant intention from memory (McDaniel & Einstein, 1992).  The noticing-plus- 
search model reflects one example of a multi-component model that seeks to specify 
the functional characteristics of the prospective and retrospective components of 
prospective memory (Einstein & McDaniel, 1996).  In this model, ‘noticing’ is 
thought to reflect a familiarity based process that supports the detection of prospective 
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memory cues when they are encountered in the environment.  In contrast, directed 
search is thought to reflect a more consciously controlled process that serves to 
attribute meaning to cues that are recognized.  Research indicates that the success of 
prospective memory is modulated by the relative distinctiveness between the 
prospective memory cues and stimuli presented in the ongoing activity (Einstein & 
McDaniel, 1990).  This is consistent with the idea that noticing is a relatively 
automatic process. 
West et al. (2001) suggests that attentional processes also may contribute to the 
detection of prospective memory cues.  West & Craik (2001) add that the efficiency of 
prospective memory may also be modulated by the context within which a cue is 
imbedded and that this reflects a failure to detect a prospective memory cue rather 
than an inability to retrieve the intention associated with the cue from memory.  These 
researchers also suggest that age-related differences in the prospective component of 
memory for intentions tend to be greater than age-related differences in the 
retrospective component of memory for intentions.  This last finding seems 
inconsistent with the idea that an automatic process supports the detection of 
prospective memory cues because automatic processes are thought to be relatively 
immune to the effects of aging (Hasher and Zacks, 1979). 
Research that has examined the correlations among age, prospective memory 
and measures of processing resources has produced variable results (West, 2004).  The 
study by West & Craik (2001) observed significant correlations between prospective 
memory and measures of processing resources such as speed, inhibition and working 
memory. They found that the relationship between age and prospective memory was 
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no longer significant when variance shared with processing resource variables was 
statistically controlled.  In contrast, Park et al. (1997) did not observe significant 
relationships among prospective memory, age and measure of processing speed 
resources.  Although beyond the scope of this thesis, West (2004) details evidence 
from neuropsychological and functional neuroimaging studies to suggest that the 
effects of aging on prospective memory ability appears to result from a decline in the 
functional integrity of the neural mechanisms that are mediated by the frontal lobes 
and which support intention formation, maintenance of intentions over time, and the 
detection of prospective memory cues. 
  Executive Functioning.  The CSMS consists of an executive functioning task 
which simulates a component of a real-life medication routine.  This component 
requires the participant to organize pills in a medication planner according to the 
previously presented hypothetical prescription medication information. 
Executive functions are considered as the most complex of behaviors and 
intrinsic in the ability to respond adaptively to novel situations.  They form the 
foundation of many cognitive, emotional and social skills.  The executive functions 
can be conceptualized as having four components which include volition, purposive 
action, effective performance and planning.  Each involves a set of activity-related 
behaviors (Lezak, et al, 2004).   
The identification and organization of the steps and elements (e.g., skills 
materials) needed to carry out an intention or achieve a goal constitute planning and 
involve a number of related capacities.  In order to plan, one must be able to 
conceptualize changes from the present to the future (look ahead), deal objectively 
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with oneself in relation to the environment and view the environment objectively.  
Planning also involves ability to generate and evaluate alternatives, make decisions 
and process both sequential and hierarchical ideas necessary for the development of 
conceptual framework or structure that will give direction to the carrying out of a plan.  
Good impulse control, sustained attention and reasonably intact memory functions are 
also necessary.  Those who are unable to form realistic intention also cannot plan.  In 
addition, some who generate motives and initiate goal-directed behavior also fail to 
achieve their goals because one or more of the requisite abilities required for effective 
planning is impaired  (Lezak, et al, 2004).   
There is a growing body of research relating to cognitive aging and which 
supports evidence of age-related deficits in executive functioning (Fisk & Sharp, 
2004; Fisk & Warr, Ven der Linden, et al. 1998).  Therefore, some older adults who 
have the best intention and who are motivated to take their medications as planned and 
as prescribed may have difficulty or be unable to successfully follow a medication 
regimen as a result of difficulty with executive functions.   
Although these processes are likely to share some common elements, research 
by Miyake et al. (2000), involving a factorial analysis showed that they may be 
separable.  In that study, various tests of executive functioning loaded more heavily on 
just one or two operations. For example, the Wisconsin Card Sort Test was shown to 
load primarily on shifting, the Tower of Hanoi problem on inhibition, and tasks of 
complex memory span loaded on updating.  Different aspects of random number 
generation were found to load on both updating and inhibition processes. These 
researchers caution however, that the study was conducted using a sample of young 
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adults and that it is unclear whether the same factor structure would be maintained in a 
more heterogeneous group.  Therefore, more research is needed to assess any potential 
differences across the adult age span. 
  Although previously described research suggest that rote maintenance abilities 
may be relatively spared in normal aging, research by Reuter-Lorenz & Sylvester 
(2004) believe that both the rote maintenance abilities decline with age.  Their 
research suggests that executive processes simply compensate for declining 
maintenance operations, which reduces the typically observed performance declines 
on assessment measures.  They describe this as a selective compensatory process 
because the reverse cannot occur.  Executive functions may compensate for 
maintenance processes but maintenance operations are unable to assume executive 
functions.  Therefore, performance declines are most evident when there are declines 
in the performance of the executive functions because they are no longer able to 
compensate.  In addition, they also believe that even with increased reliance on 
executive processes in the service of simpler storage tasks, there is less executive 
processing resource available to meet the increased task demands which again may 
cause impaired performance in such functions to be more evident. 
  One of the most widely used psychometric tests to assess aspects of executive 
functioning is the Wisconsin Card Sort Test (WCST; Milner, 1963; Nelson, 1976; 
Heaton 1981).  The test involves problem solving, concept formation, and planning 
ability in that it requires subjects to sort cards presented by the examiner according to 
criteria that must be inferred from correct or incorrect responses.  Based on continuous 
feedback (e.g. correct or incorrect) from the examiner, the subject must generate a 
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solution and then make a decision to sort each card according to color, shape or 
amount.  The work of Miyake et al. (2000) suggests that the WCST is primarily 
dependent on the shifting component of the executive processes, however other 
research (Wang et al., 2001) has also implicated the updating and inhibition processes.  
This research suggests that when a category shift in the test occurs, the former 
response or “mental set” must be inhibited.  In addition, each time the category of the 
test changes, the working memory has to be updated. 
In a study of medication management using 41 adult inpatients diagnosed with 
schizophrenia, Johnson (1998) used a number of variables to predict success in a 
medication management program.  Among other assessment tools, this study used the 
WSCT to assess components of executive functioning in addition to the dose planning 
task of the CSMS which was also believed to be related to executive functioning 
ability.  A regression analysis identified a number of variables that predicted success 
in the medication management program.  The first was identified as the performance 
on the dose planning task of the CSMS.  This task involved the ability to accurately 
fill a dose planner according to a hypothetical prescription and is believed to assess the 
planning component involved in executive functioning.   
In the same study, the second variable which was predictive of success in the 
medication program was an interaction variable consisting of the number of 
perseverative errors on the WCST and performance on the dose planning task of the 
CSMS.  The perseverative errors of the WCST were predictive of success in the 
program, but only if the subject was able to perform well on the dose planning task of 
the CSMS.  Therefore if a subject performed well on the dose planning task of the 
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CSMS, the WCST provided more valuable information in terms of predicting success 
in the medication management program. On the contrary, if a subject performed 
poorly on the dose planning task of the CSMS, the perseverative errors on the WCST 
was no longer predictive of success in the medication management program. 
The research of Johnson (1998) lends support for the predictive criterion validity 
and the ecological validity of the dose planning task of the CSMS.  The observed 
relationship between the dose planning task of the CSMS and the WCST also appear 
to provide evidence to support the cognitive construct validity of the dose planning 
task of the CSMS.  The ability to perform the dose planning task appears related to 
executive functioning ability and was found to be an integral and predictive 
component of successful medication management.  
In addition, these results seem to support evidence of the multi-component 
nature of the executive system and the potential sensitivity of specific executive 
components in predicting success in a medication management program.  The 
planning (as measured by the CSMS dose planning task), shifting and inhibition 
components (as measured by the perseverative errors of the WCST) of the executive 
system all appear to be important factors in successful medication management.  
Although the planning, shifting and potential inhibition aspects appear to be important 
components of predicting success in the medication program, it seems that, for 
schizophrenic inpatients, the success in the medication program may be better 
predicted by a test which loads more on the planning component of the executive 
system. 
As the ability to follow a medication routine may involve elements of planning, 
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organizing, initiating and shifting behaviors, executive functioning ability appears to 
be another fundamental, yet complex, cognitive construct which is relevant to 
medication adherence and management.  A number of previously described 
assessment tools assessing medication management also involve tasks related to 
medication planning aspect of executive functioning (Meyer & Schuna, 1989; Spiers, 
1994; Edelberg et al., 2000). 
Psychometrics and Test Construction 
Establishing sound psychometric properties is a critical and fundamental step in 
the process of test development.  In the same way new medications are rigorously 
tested for their effectiveness, it is important for neuropsychological measures to be 
developed and evaluated in a similar manner.  Testing of psychological measures 
includes establishing validity and reliability.  Gregory (1996) states that the merit of a 
psychological test is determined by its reliability, and then ultimately by its validity. 
While there are various types of reliability and validity which are crucial to the 
process of test construction, this study utilized subject data from a previously collected 
database and as a result, will be limited to examining only one form of reliability 
which is in terms of internal consistency.  While previous research using the CSMS 
has begun to examine various aspects of validity which are discussed in the literature 
review, the primary focus of the  study will involve examination of the discriminative 
and convergent aspects of the CSMS construct validity.  
Reliability as Internal Consistency.  The entire CSMS is comprised of a number 
of heterogeneous tasks of medication taking, however some of the tasks are likely to 
be psychometrically homogeneous in nature.  As it would not be useful to examine the 
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internal consistency of the CSMS as a whole, an examination of the individual 
subscales seems more appropriate.  This study will be the first to examine the 
reliability of the CSMS as measured by the internal consistency of each of the primary 
scales.   
According to Smith & McCarthy (1995), the proper refinement of outcome 
measures is a two phase process.  While the second phase involves the assessment of 
degree of the relationship between the instrument and other important variables, the  
first phase involves the identification of the instrument’s factor structure and 
estimation of its internal consistency.  Assessment of the reliability of a measure is 
important because it allows for the generalization of results obtained by the measure.  
Without reliability, validity cannot be established (Nunally & Bernstein, 1994). 
Reliability is a key psychometric characteristic of test scores and not of an entire 
test, per se and reliability of test scores is evaluated from two primary perspectives. 
The first involves the relative accuracy of a single score taken at a single point in time 
while the second involves the relative stability or degree of repeatability of a score 
over a defined time period (Reynolds, 2001).  Since this current research involves 
subjects who were administered test items on only one occasion, the focus of this 
study will be limited to the analysis of reliability as internal consistency, as opposed to 
test-retest reliability. 
Although internal consistency is sometimes referred to as “split-half reliability”, 
it is not reliability in the sense of measuring how well a scale will produce the same 
results on different occasions when the target phenomena are expected to remain 
constant.  It is important note that some scales with relatively low internal consistency 
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may be more valid than some scales with very high internal consistency (Achenbach 
& Rescorla, 2001). 
Internal consistency refers to the homogeneity of the items within a measure. 
Homogeneity however, relies heavily on the relative homogeneity of the domain.  The 
more homogeneous a domain, the higher the internal consistency tends to be.  As a 
result, domains that measure more than one construct are likely to have lower levels of 
internal consistency due to the nature of the domain.  A common and accurate method 
of assessing internal consistency or the relative accuracy of a test score is through the 
calculation of an internal consistency reliability coefficient.  The most general of these 
methods is Cronbach’s coefficient alpha (Reynolds, 2001).    Alpha is the average of 
the correlations between all theoretically possible split half versions of a test, corrected 
for the length of the test.  Cronbach (1951) has shown that coefficient alpha is the 
general application of a more specific formula which was developed earlier by Kuder 
and Richardson (1937).  The Kuder-Richardson formula was relevant to test scores in 
which test items were scored 0 or 1 (e.g wrong or right).   Coefficient alpha extends 
the Kuder-Richardson method to types of tests with items that are not scored 0 or 1 
and to those that may have more than 2 possible response choices.  For example, 
coefficient alpha can be used with an attitude scale in which examinees indicate on 
each item whether they agree, strongly agree, disagree or strongly disagree.  In order 
to accurately assess the internal consistency of a test with multiple scales or subtests 
such as the CSMS, it is more appropriate to report the reliability coefficients for each 
scale or task (Kazdin, 1998).   
While some of the subtests of the CSMS are comprised of only a few items, the 
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internal consistency of those components is not likely to demonstrate a high level of 
homogeneity, however the examination of those subtests which have a relatively 
greater number of items may demonstrate higher levels homogeneity, if the items of 
the components are, in fact measuring similar constructs. 
Test Validity 
Researchers and clinicians have an ethical responsibility to use tests which are 
valid and reliable and to demonstrate that new instruments fulfill the purposes for 
which they were designed.  Gregory (1996) summarizes the validity of a test as the 
extent to which it measures what it claims to measure.  According to Gregory, many 
psychometricians have long acknowledged that validity is the most fundamental and 
important part of a test because it is that which actually defines the meaning of test 
scores.  As a result, an individual test score is meaningless until the examiner draws 
inferences from it based on the test manual and associated research findings.  
Adhering to the concepts of validity and reliability allow researchers to develop 
psychometrically sound measures and provide a systematic method to assess the worth 
and effectiveness of the test and its ability to measure what it claims to measure 
(Anastasi, 1982). 
Valid tests, however, do not just appear in full maturity.  Gregory (1996) 
describes a process in which valid tests emerge slowly from an evolutionary and 
developmental process.  Therefore, it is crucial that issues of validity be considered 
from the initial stage of the test construction, as opposed to being limited only to the 
final stage of test development. Test validation can be viewed as a process that begins 
with test construction and one which can continue indefinitely.  Anastasi (1986) views 
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test validity as “a living thing; it is not dead and embalmed when the test is released.”  
After a test is published and released for operational use, the interpretive meaning of 
the test scores may continue to be refined and enriched through the gradual 
accumulation of clinical observations and research and through the continued 
application of the scientific method.  Although reliability is also important, it is only 
so in that constrains validity.  Therefore, reliability is a necessary, but not sufficient 
precursor of validity. While validity refers to the extent that a test is measuring what it 
claims to measure, reliability addresses the consistency of the measure (Kazdin, 1988). 
Gregory (1996) highlights the importance of understanding that it is impossible 
to summarize the validity of a test in terms of a single, “tidy” statistic.  Determining 
whether inferences are appropriate, meaningful, and useful typically require numerous 
investigations about the relationships between test performance and other 
independently observed behaviors.  The validity of tests is not captured by neat 
statistical summaries but rather described on a continuum ranging from “weak” to 
“acceptable”, to “strong”.  Virtually any empirical study that relates test scores to 
other findings is a potential source of validity information (Anastasi, 1986;  Messick, 
1989).  Although most researchers agree on the definitions of the various forms of 
validity, not all agree on how to categorize the various forms and the methods of 
testing validity.  For consistency, clarity and brevity, the discussion of validity for this 
thesis will be divided into the three categories outlined by Anastasi (1982) and 
Gregory (1996) consisting of content, criterion and construct validity. 
Content Validity.  A number of researchers (Gregory, 1996; Bausell, 1996; 
Kazdin, 1998), describe content validity as determined by the degree to which the 
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questions, tasks or items on a test are representative of the universe of behavior that 
the test was designed to sample.  In theory, content validity involves an issue of 
sampling.  The items of a test can be visualized as a sample drawn from a larger 
population of potential items that define what a researcher really wishes to measure.  
Content validation requires a methodological review of the test items to determine 
whether it is, in fact, a representative sample of the domain being measured (Anastasi, 
1982).  If the sample of specific items on the test is representative of the population of 
all possible items, then the test possesses content validity. 
In order for a measure to achieve adequate content validity, test items must have 
relevance and representativeness (Haynes, Richard & Kubany, 1995).  The relevance 
of a measure is determined by the appropriateness of the items and their ability to 
characterize the target construct.  The relevance of a measure, may therefore be 
impaired because it the item is beyond or outside of a relationship with the target 
construct.  The degree to which items are proportional to the constructs of the area of 
study provide information regarding the representativeness of a measure. 
A number of researchers (Lawshe, 1975; Martuza 1977) have described 
statistical methods for determining the overall content validity of a test from the 
judgment of experts.  These methods tend to be very specialized and serve as a model 
of inter-rater agreement as a basis for content validity.  An example of this is the 
Content Validity Ratio (CVR) methodology described by Veneziano & Hooper 
(1997).  Like other methods of content validation, CVR requires the measure to be 
reviewed by a panel of experts within the field of study who rate each item as 
“essential,”  “useful but not necessary” or “not necessary” for each construct. Items 
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that are rated “essential” by more than 50% of the reviewers are considered to possess 
adequate content validity to be retained in the measure.   
While this approach to content validity is useful in helping to eliminate existing 
items which are deemed inappropriate by expert raters, it does not identify non-
existent items or tasks that should be added to the test to make the pool of items more 
representative of the intended domain. In theory, as Gregory (1996) asserts, a test may 
possess an adequate coefficient of content validity yet still lack elements which would 
make the items more representative of the domain under investigation.  Therefore, 
quantification of content validity is no substitute for the careful and selection of items 
based on existing theoretical and empirical research. 
Although the content validity of the tasks of the CSMS has not been formally 
assessed, the 13 tasks of the CSMS test were developed from a review of previous 
functional measures and a theoretical analysis of the component skills that mimic the 
abilities associated with following a medication regimen.  Although the test items are 
likely to be an adequate representation of the pool of motor, sensory and cognitive 
skills that are known to be associated with a medication taking routine, studies to 
further support the content validity of the CSMS are needed. 
Criterion Validity.  According to texts by Anastasi (1982), Gregory (1996) and 
Kazdin (1998), criterion-related validity is demonstrated when a test is shown to be 
effective in estimating an examinee’s performance on some outcome measure.  Within 
this context, the criterion is the outcome measure and refers to a “direct and 
independent” measure of that which the test is designed to predict.  Criterion validity 
refers to the correlation of the measure with the criterion.  
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A criterion must be reliable if it is to be a useful index of what the test 
measures (Gregory, 1998).  As the reliability is related to the consistency of the scores, 
an unreliable criterion will be inherently unpredictable, despite the merits of the test. 
Criterion measures should be described accurately and in addition, the rationale for 
using them as the relevant criteria should also be adequately explained.  In their 
chapters about validity, Anastasi (1982), Gregory (1996) and Kazdin (1998), describe 
concurrent validity and predictive validity as two types of criterion-related validity. 
In concurrent validity, the criterion measures are obtained at approximately the 
same time as the test scores.  An assessment of concurrent validity indicates the extent 
to which test scores accurately estimate an individual’s present position on the 
relevant criterion and a test with demonstrated concurrent validity provides a short-cut 
for obtaining information which may otherwise require an extended amount of 
professional or clinical time.  Although not a replacement for clinical specialists, these 
tests can be help clinicians save time in the initial phase of diagnosis. 
According to Gregory (1996), correlations between new tests and existing tests 
are often cited as examples of concurrent validity.  Within this context, it appears as if 
an old test is validating a new test, however this method is appropriate if two 
important conditions are met.  First, the criterion (existing tests) must be validated 
through correlations with the appropriate non-test behavioral data.  In other words, the 
network of relationships must be associated with real-world behavior.  Second, the 
instrument being validated must measure the same construct as the criterion tests.  An 
example of this is seen in correlational studies of two intelligence tests such as the 
Wechsler and Stanford-Binet scales. 
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Some previous research using the CSMS has demonstrated evidence of 
concurrent criterion validity.  A study by Lamar et al. (1999), demonstrated a 
significant relationship between scores from the CSMS Prescription Memory Test and 
the previously established CVLT-9 test of memory.  In the same study, the CSMS 
Prescription Memory Test was also found to be more sensitive than the CVLT-9 in 
differentiating between a group of impaired and unimpaired older adults.  
In a predictive validation study, test scores are used to estimate outcome 
measures obtained at a future date.  It refers to the correlation between the measure 
under investigation and the criterion at a later time.  Predictive validity is often crucial 
for tests such as entrance examinations and employment tests in that it determines who 
is likely to succeed at a future endeavor or task. 
According to these definitions, concurrent and predictive validity differ not 
only on temporal issues but in their objectives as well.  Concurrent validation is used 
to validate tests utilized for the support of an existing diagnosis or status, while 
predictive validation is used to asses a measure’s ability to predict future outcomes. 
In regards to predictive criterion validity, a study by Johnson (1999) using the 
dose planning task of the CSMS has demonstrated the ability to predict success in a 
psychiatric inpatient medication program.  In that same study, the CSMS dose 
planning task score was also found to be a better predictor of medication program 
success than a score from the Wisconsin Card Sorting test. 
Construct Validity.  While previous studies have begun to support various 
aspects of the predictive, concurrent and criterion related validity of the CSMS, this 
study aims to identify the various cognitive and sensory components involved in 
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medication taking.  As a result, this study will primarily involve providing further 
supporting evidence of the construct validity of the measure and identifying the 
convergent and discriminant relationships between the tests of medication taking and 
global cognitive ability.   
The concept of construct validity is fundamental to the process of test 
development.  Construct validity pertains to psychological tests which claim to 
measure complex, multi-faceted and theory-bound psychological attributes or 
“constructs” such as intelligence.  In a classic article involving construct validity, 
Cronbach and Meehl, (1955), highlight the importance of understanding that “no 
criterion or universe of content is accepted as entirely adequate to define the quality to 
be measured”.  As a result, the demonstration of construct validity is dependent upon a 
pattern of research using a number of diverse procedures.  Construct validity then is 
viewed by many psychometric theorists as a conceptual framework which unifies 
individual studies of content, concurrent and predictive validity as merely supportive 
evidence in an ongoing and cumulative process of construct validation (Gregory, 
1996).   
A number of stages necessary to establish construct validity were described in 
the article by Cronbach and Meehl (1955) and later by Clark and Watson (1995).   
In the initial stage of establishing construct validity, the theoretical concepts must be 
thoroughly defined and integrated.  This stage involves a comprehensive review of the 
relevant research and literature.  Once the relevant theories are outlined and integrated, 
specific methods to measure the hypothesized constructs can be developed. This stage 
often involves generation and selection of test items.  In the later stage of assessing 
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construct validity, hypotheses can be generated and tested through a series of 
systematic and empirical investigations. 
Convergent validity is demonstrated when a test correlates highly with other 
variables or tests that it shares an overlap of constructs with (Anastasi, 1982; Gregory, 
1996; Kazdin, 1998).  This is done in order to provide evidence that the measure under 
investigation is in the same theoretical domain as the established measure.  For 
example, two tests designed to assess different types of intelligence should share 
enough of the general factor in intelligence to produce an adequate correlation of .5 or 
greater when administered to a diverse sample of subjects.  If any new test of 
intelligence did not correlate at least modestly, with an existing measure, it does not 
have convergent validity. 
As opposed to the correlations discussed in criterion related validity, Anastasi 
(1982) cautions that correlations with other tests should be moderately high but not too 
high.  If tests correlate too highly and the new test does not possess any advantages 
such as ease of administration or reduced time to administer, then the test is likely to 
add little or nothing to the theoretical construct under investigation.  This renders the 
test redundant or even unnecessary. 
As the CSMS is purportedly comprised of a number of cognitive components, 
those components would most likely demonstrate a convergent relationship to tests of 
general cognitive ability.   While the CSMS as a whole is comprised of a 
heterogeneous set of medication taking tasks, there are also likely to be a number of 
interrelated and convergent cognitive components within the component structure of 
the CSMS.  
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  Discriminant validity is demonstrated when a test does not correlate with 
variables or tests from which it is expected to differ from (Anastasi, 1982; Gregory, 
1996; Kazdin, 1998).  The lack of correlation is based on separate theoretical 
conceptualizations of the constructs being measured.  Discriminant validity helps 
determine if a new measure actually encompasses a new construct or is simply 
associated with or “taps into” an existing or more well-established construct. 
  While the CSMS is comprised of both cognitive and sensory components, it is 
likely that the cognitive components may be well differentiated from the non-cognitive 
components.  As a result, the component structure of the CSMS is also likely to 
demonstrate discriminant relationships between the cognitive and sensory tasks of the 
CSMS. 
The previously described research using the CSMS has contributed to the 
preliminary establishment of the test’s content and construct validity.  In addition, the 
earlier described pilot studies (Johnson, 1998;  Lamar et al., 1998) using the CSMS 
with various subject populations (e.g. schizophrenics, older adults) and with 
previously validated assessment measures (e.g. MMSE, CVLT-9  & Wisconsin Card 
Sort Test), have also begun to establish aspects of concurrent and predictive criterion 
validity.  This study aims to further contribute to the evidence supporting the construct 
validity by identifying the cognitive and sensory components of the CSMS and the 
skills involved in understanding, learning and executing a medication routine. 
Ecological Validity.  Tupper and Cicerone (1990) define ecological validity as 
the degree to which results obtained in controlled experimental conditions are related 
to those obtained in naturalistic environments.  In the context of neuropsychological 
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testing, ecological validity refers to the degree in which test performance corresponds 
to real world performance.  Validity does not apply to the test itself, but to the 
inferences that are drawn from the test (Franzen & Arnett, 1997).  Therefore, test 
results which may have adequate diagnostic validity may not necessarily have 
adequate ecological validity. 
According to Chaytor & Schmitter-Edgecombe (2003), evaluating the 
ecological validity of neuropsychological tests has become an increasingly important 
topic over the past decade.  Whereas physicians have traditionally been the primary 
referral source for neuropsychological assessments, other agencies such as schools, 
employers, attorneys and insurance companies are now beginning to utilize the 
services of neuropsychology more frequently.  This change has resulted in a shift in 
the types of questions that are being asked of neuropsychologists.  Referrals are 
shifting away from diagnostic questions to questions regarding the client’s everyday 
cognitive abilities and disabilities.  Referral sources want information regarding 
suitability for rehabilitation programs, ability to return to work, ability to drive a 
vehicle, or to live independently (Sbordone, 1997). Chaytor & Schmitter-Edgecombe 
(2003) suggest that clinicians have adapted to the new set of questions, simply making 
recommendations about client’s everyday functioning based on traditional 
neuropsychological test performance. Unfortunately, they argue, that many of the tests 
themselves have not changed along with the referral questions, so the same tests which 
were developed to answer diagnostic questions are now commonly used to answer 
questions regarding real-world functioning. Much of this practice occurs with little 
empirical evidence to support it.  Because the recommendations that 
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neuropsychologists make concerning everyday functioning have far reaching 
consequences for clients’ lives, Chaytor & Schmitter-Edgecombe (2003) underscore 
the importance of demonstrating the ecological validity of the neuropsychological 
measures being employed. 
Franzen and Willhelm (1996) identify the verisimilitude and verdicality as two 
conceptual approaches to address the problems of ecological validity of assessment 
instruments.  Verisimilitude is the degree to which the cognitive demands of a test 
theoretically resemble the cognitive demands in the everyday environment. Chaytor & 
Schmitter-Edgecombe (2003) report that this approach typically requires abandoning 
our existing tests and creating new assessments with ecological goals in mind.  These 
tests tend to be more face valid than traditional tests and attempt to simulate critical 
everyday cognitive tasks.  Because the CSMS mimics real-life tasks of medication 
taking, it appears to possess adequate face validity and a high degree of verisimilitude. 
The primary focus of these measures may not be how well they discriminate 
brain injured from normal individuals, but rather on how well these tests capture the 
essence of everyday cognitive skills and functions.  The primary purpose of these 
tasks is to identify people who have difficulty performing real world tasks, regardless 
of the cause of their problem.  A measure which identifies those at risk for problems 
with medication management and adherence is likely to have practical clinical 
applications in helping remediate the problem. 
Verdicality refers to the degree to which existing tests are empirically related 
to measures of everyday functioning.  Typically, this type of research involves the use 
of statistical techniques to relate performance on traditional neuropsychological tests 
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to measures of real-world functioning. As a result, even though traditional tests were 
not designed with ecological validity in mind, they may still be predictive of everyday 
cognitive skills. 
Chaytor & Schmitter-Edgecombe (2003) report that verdicality and 
verisimilitude have a number of strengths and limitations as applied to the ecological 
validity of neuropsychological tests.  At a minimum, versimilitude only requires that 
tests are conceptually similar to everyday situations, so using the versimilitude 
approach alone lacks empirical rigor, as no empirical data are inherently needed to 
claim that a test is similar to everyday situations.  Even if most people agree that a test 
is similar to an everyday task, there may still be aspects of the testing situation that 
limit the applicability to the real-world.  Without empirical evidence, we cannot be 
sure that a test with verisimilitude is ecologically valid.  Additionally, these authors 
argue that developing new tests is often a costly process and requires that established 
clinicians adopt the use of these tests.  While neuropsychologists have historically 
been cautious about adopting new methods and shifting perspective on the way in 
which they conduct aspects of their profession (Williams, 1988), Chaytor & 
Schmitter-Edgecombe (2003) agree that there is often reluctance from clinicians to 
adopt the use of new and unfamiliar tests.  Therefore, attempting to establish the 
ecological validity of existing tests (verdicality) may prove to have a broader impact 
on the practice of neuropsychology. It is also possible that our existing tests may not 
have adequate ecological validity because they were not designed with this as the 
purpose, and as a result, it may be more difficult to demonstrate the ecological validity 
of existing tests. 
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As the CSMS was developed using simulated tasks of an actual medication 
routine, the ecological validity of the test is believed to have a high degree of 
verisimilitude.  Although previous pilot studies using the CSMS have begun to 
explore the relationships between traditional neuropsychological measures such as the 
Wisconsin Card Sort and the CVLT-9.  Although this study will not involve a direct 
examination of ecological validity, suggestions will be made to facilitate more 
empirical research to further establish and strengthen the verdicality aspects of the 
test’s ecological validity. 
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Purpose and Rationale of this study 
Previously conducted research involving medication adherence has identified a 
number of factors which contribute to poor adherence to a medication regimen.  More 
specifically, age-related cognitive decline has been observed to be relevant factor 
contributing to the difficulty that older persons have in understanding and managing a 
medication regimen.   A number of tests that attempt to measure and predict 
medication adherence and various elements of medication management have been 
developed and used over the years, however there is currently no “gold standard” 
assessment measure for this purpose.  While many studies of medication adherence 
assess post-hoc adherence, few have been focused on examining the various sensory, 
motor and cognitive substrates responsible for understanding and executing a 
medication regimen before the regimen has been initiated.  While some of these 
studies using other tests of medication adherence and management have been 
validated using specific medications with specific medical conditions or in identifying 
demented from normal subjects, none of the previously reviewed measures have 
attempted validation from populations, such as the elderly, which may be more 
vulnerable to experiencing difficulties with the skills involved in medication taking 
and adherence. 
The Cognitive Screen for Medication Self-Management (CSMS) was developed 
by Spiers (1994) to assess a comprehensive array of motor, sensory and cognitive 
substrates which are necessary for understanding and executing a medication regimen. 
The individual tasks of the CSMS were developed to simulate a real-life medication 
routine. 
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The goals of this study are: 
1) to evaluate specific identified psychometric properties of the CSMS 
including 
a. the construct validity of the  motor, sensory and cognitive     
  components of the CSMS.  
b. and the internal reliability and item difficulty of the primary tasks  
  of  the CSMS. 
2) to provide further evidence of the validity of the CSMS scales using a 
sample of older adults to examine: 
    a. the effect of cognitive status on CSMS performance by using two  
     cognitive status groups, differentiated using the MMSE 
b. and the effect of age on CSMS performance in a cognitively intact 
group using three different age groups of older adults. 
Previous work examining the CSMS has already begun to establish various 
aspects of predictive and concurrent criterion-related and convergent construct 
validity, using performance scores on the CSMS from  samples of older adults. This 
current study, using a sample of independently living older adults will help further 
establish various aspects of construct validity and also identify which subtests and 
skills of medication management may be more vulnerable to the effects of aging and 
age-related cognitive decline.   
In addition, this study will also identify other salient psychometric properties 
such as the reliability (internal consistency) and item difficulty on the fundamental 
CSMS tasks, in addition to making suggestions for the most efficient and useful 
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method of scoring this test of medication self-management. Examining the 
psychometric properties of the CSMS will be achieved by analyzing performance 
scores on each of the individual CSMS tasks, their relationship to demographic 
variables and the identified constructs, and their consistency with previous theories of 
medication management, aging and cognitive functioning. 
An outcome of the this study will be to provide specific recommendations for 
improving the clinical utility and the ecological validity of the CSMS which may help 
guide future research in the area of medication adherence and management, in addition 
to providing the relevant information necessary to begin development of a formal 
manual of administration, scoring and interpretation.  
Hypotheses 
  HYPOTHESIS 1: Scores from all four CSMS memory tasks and the dose 
calculation task were predicted to form a unified cognitive component related to 
memory and calculational ability while the dose planning task was predicted to form a 
single cognitive component related to the planning and organizational aspects of 
executive function ability.  The scores for study time and arrangement time were 
predicted to comprise a single component of processing speed.  Label reading and 
clock reading were predicted to comprise a visuosensory component and the bottle 
opening task was predicted to form a sensoriomotor component.  
This first hypothesis of the study involves the factor structure of the CSMS 
performance scores and the convergent and discriminant relationship among the 
various CSMS tasks of cognition, processing speed and sensory ability. 
Since previous research has demonstrated convergent relationships between 
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retrospective memory, prospective memory, and calculational/working memory 
processes, the scores for all the memory tasks (immediate recall, delayed recall, cued 
recall, and prospective memory) and the dose calculation task were predicted to 
emerge as the primary cognitive component of the CSMS.   The dose planning score, 
representing planning and organizing abilities was likely to emerge as a single factor 
and as there is some research that suggests a convergent relationship between planning 
and organizing with memory abilities, some communality with the memory 
component was expected.  While there is likely to be a convergent relationship 
between study time and arrangement time scores, it was predicted that both would 
emerge as a unified component of processing speed. 
The factor structure of the CSMS performance scores is likely to demonstrate a 
discriminant relationship between the sensorimotor and visuosensory tasks of the 
CSMS.   Therefore, it was predicted that the bottle opening task would emerge as the 
sensorimotor component and that the label reading and clock reading tasks would 
comprise a separate visuosensory component. 
 HYPOTHESIS 2.  The CSMS scores which are purported to be primarily 
cognitive in nature are predicted to show correlations of moderate strength with the 
MMSE total score.  The cognitive scores of the CSMS which are predicted to be 
associated with the MMSE score are the dose calculation score, the two processing 
speed scores (study time and arrangement time), the dose planning score and all of the 
memory scores (immediate recall, delayed recall, cued recall and prospective 
memory). 
  The visuosensory and sensorimotor tasks were predicted to be independent of 
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cognition.  No significant correlations between the MMSE and either the CSMS bottle 
opening or label reading scores were predicted.  In addition, since the clock reading 
task is purported to be a highly over-learned ability requiring very little effortful 
cognitive processing, no significant correlation is predicted between the CSMS clock 
reading total score and the MMSE total score. 
  HYPOTHESIS 3:  In a comparison of two groups, differentiated by cognitive 
status as assessed using the MMSE, the intact (i.e. higher scoring) group is predicted 
to demonstrate better performance for the CSMS cognitive tasks (dose calculations, 
dose planning, immediate recall, delayed recall, cued recall and prospective memory) 
and processing speed tasks (study time and arrangement time) than those of a mildly 
cognitively impaired (i.e. lower scoring) group.  
  No cognitive group performance effect on the label reading, bottle opening or 
clock reading tasks was predicted.   
  HYPOTHESIS 4:  In a comparison of CSMS performance among three different 
older age groups, younger people are predicted to perform better on the cognitively 
related CSMS task scores (including dose calculations, dose planning and all of the 
memory tasks (immediate recall, delayed recall, cued recall and prospective memory) 
except for clock reading.  Those in the younger groups are also predicted to 
demonstrate better performance on the cognitive, sensory and processing speed tasks 
of the CSMS than those in the older groups. 
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METHODS 
The methods of this study have been developed to provide evidence to support 
the construct validity of the CSMS.  The study will use approaches, consistent with 
Gregory (1996; pp.119-124) to support aspects of the construct validity of the CSMS 
subtests.  These include an examination of the principal components of the primary 
CSMS performance task variables through factor analysis, in addition to analyses of 
task homogeneity, correlation with the MMSE test of global cognitive status, and an 
examination of theory consistent group differences based on cognitive-status assessed 
using the MMSE and appropriate developmental (age-related) changes. 
Data Analysis Strategy 
1.  The study will utilize a principal components and factor analysis to help 
identify the underlying factor structure and the relationship of the fundamental motor, 
sensory and cognitive components of the CSMS test.  This analysis will also help 
determine the homogeneity of the CSMS subtest items and to identify the scales which 
may measure a single construct (discriminant validity) and to identify any 
interrelations between the CSMS scales which may share variance and overlap with 
differing constructs (convergent validity).   
The task variables of the CSMS which are believed to be primarily cognitive in 
nature involve aspects of retrospective and prospective memory, calculational and 
dose planning ability, speed of processing and clock reading.  The scores which were 
used to assess retrospective memory include the total scores of the CSMS for 
immediate recall, delayed recall and cued recall.  The scores which were used to 
assess processing speed are the CSMS total scores for arrangement time and study 
 57
time.  Total scores for the CSMS dose calculation task, the dose planning task and the 
clock reading tasks were also used. 
In addition to the cognitive tasks, the CSMS is also believed to assess a number 
of sensory abilities related to medication taking. These involve sensorimotor and 
visuosensory abilities.  The score used to assess sensorimotor ability will be the bottle 
opening task total score while the score used to assess visuosensory ability (visual 
acuity) will be the score from the CSMS label reading task. 
2.  To further explore the discriminant and convergent construct validity of the 
sensory and cognitive CSMS scales, this study will compare performance of the 
participants classified as cognitively intact and those classified as mildly impaired 
using the MMSE as a criterion.   In addition, another comparative study using a 
subsample of the oldest-old participants among the two cognitive groups will provide 
some preliminary evidence of the potential interaction effect of both age and cognitive 
status on the performance of the CSMS tasks. 
3.  Correlations of the CSMS subtest scores with scores on the Mini-Mental 
Status Exam will also be examined to identify aspects of concurrent criterion-related 
validity.  One-tailed Pearson correlation coefficients will be used to examine 
associations between these variables and the a-priori level of significance for all 
statistical analyses of this study will be p < .05. To further examine aspects of the 
homogeneity of the CSMS subtests, the internal consistency form of reliability as 
described by Gregory (1996, pp. 94-97) will be calculated for the subtests designed to 
assess a single component of medication taking.  These include tasks for bottle 
opening, dose calculations, clock reading and the memory tasks of immediate, delayed 
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and free recall. 
4.  Many behavioral, psychological and cognitive constructs show age-related 
developmental changes across the lifespan.  The analyses of appropriate 
developmental changes to determine if they are consistent with the theory of the 
construct under investigation is another approach to support construct validity 
(Gregory, 1996).  This study will provide a comparative age-related analysis of the 
performance of older subjects on each of the fundamental CSMS tasks across 3 
different age groups. 
5.  Lastly, in an attempt to identify the relevance of specific CSMS subtest items 
and to guide potential item inclusion or exclusion in a future revision of the test, a 
descriptive analysis of this study will also include a calculation of Cronbach's Alpha 
as an indicator of Internal Consistency and of the item difficulty index as described in 
Gregory (1996, p. 140) for select CSMS subtests.  Cronbach's Alpha and Item 
difficulty indices will be calculated for the 3 memory tasks of immediate, delayed and 
cued recall, in addition to the dose calculation, bottle opening, and clock reading tasks. 
Participants 
The sample of participants used in this study was derived from a previously 
collected database of a larger sample. Upon initial data analysis, some errors of coding 
and a confounding experimental condition were discovered and resulted in removal of 
27 participants from the study. The sample of participants in this study consist of 60 
older adults, ranging in age from 72 to 95. (M = 83.30;  SD = 5.31).   Although most 
of the participants (71.7%) had been educated beyond high school, their educational 
levels ranged from 8 to 20 years (M = 14.68, SD = 2.68).  Educational level was 
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unknown for 5 participants.  Forty-five participants (75%) were female and fifteen 
(25%) were male.  In terms of ethnicity, fifty-eight were Caucasian (96.7%) and two 
were African American (3.3%).   
Participant data was previously collected and was not conducted by this 
researcher.  All participants were recruited at senior residential facility and community 
centers in Philadelphia and the surrounding suburban area. All participants were 
community dwelling individuals who were living independently and denied being 
treated for depression and major mental illness. 
Consent for participation was voluntary.  Presentations were made by graduate 
students trained in the research methodology at Philadelphia area senior centers.  The 
presentation included general information regarding memory functioning and a 
description of the research paradigm.   After the presentation, those individuals who 
were interested in participating further were given information regarding the nature 
and purpose of the study including benefits to the participant and to the research area.  
A full description of the expectations of the participant and the duration of the 
research session was also provided in written form and reiterated verbally in a brief 
initial interview.  Researchers communicated to the participant that they could 
withdraw from the study at any time during the session with no consequences from the 
researcher or from the center in which they belonged. Participants were administered 
the research protocol in a private and quiet room at the senior center.  All participants 
were treated in a manner in accordance with the ethical standards of the American 
Psychological Association and the Drexel University IRB for the treatment of human 
participants. 
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Demographic Comparisons of Participant Subsamples 
 Intact Cognitive Group 
In the analyses of this study which compare the performance of an intact group 
of participants and a comparison cognitive group on the measures of the CSMS, a 
relatively conservative normative MMSE cutoff score of 27, as suggested by Kukull et 
al. (1994) and Lezak (1995), was used.  According to this criterion, those with MMSE 
scores of 27 or greater were classified as cognitively intact.   
The intact group of participants who had MMSE scores of 27 or greater, 
consisted of forty-six subjects.  See Table 1 for a summary of group characteristics.  
MMSE scores ranged from 27-30 (M = 28.61;  SD = .98).  The participants in this 
group ranged in age from 72 to 95 years (M = 82.39;  SD =  5.10).  Participants ranged 
in educational level from 8 to 20 years (M = 14.92:  SD = 2.60).  Educational level 
data was missing on 2 participants (4.3%).  Thirty-eight participants were female 
(82.6%) and eight were male (17.4%). Regarding ethnicity, forty-five participants 
were Caucasian (97.8%) and one was African-American (2.2%).  As a result of limited 
data in the noted subject demographic categories, meaningful comparisons of gender 
and ethnicity on performance could not be made and were thus, excluded from the 
correlational and comparative group analyses.   39 participants in this group were 
administered the GDS. The mean GDS score was 1.79 (SD = 2.38) and the scores 
ranged from 0 – 8.  
Mild Cognitive Impairment Group 
For practical, descriptive purposes of this study, the group of participants who 
had MMSE scores of 26 or less will be referred to as the mild cognitive impairment 
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group (MCI).  This comparison group consisted of fourteen subjects.  See Table 1.  
According to the criterion suggested by Kukull et al. (1994) and Lezak (1995), those 
with MMSE scores of 26 or less were considered to have at least, a mild level of 
cognitive impairment.  MMSE scores of those in this group ranged from 20-26 (M = 
24.29;  SD = 1.94).  The participants in this group ranged in age from 76 to 95 years 
(M = 86.29;  SD =  5.03).  Seven participants were female (50%) and seven were male 
(50%). Participants ranged in educational level from 8 to 19 years (M = 13.73:  SD = 
2.94).  Educational level data was missing on 3 participants (21.4%). Regarding 
ethnicity, thirteen participants were Caucasian (92.9%) and one was African-American 
(7.1%).   All fourteen participants in this group were administered the GDS. The mean 
GDS score was 4.00 (SD = 3.06) and the scores ranged from 0 – 8.   
A Pearson Chi-square was used to examine group differences among the 
categorical demographic data (gender & ethnicity) while univariate one-way 
ANOVAs were used to analyze group differences among the continuous variables 
(education, MMSE score, and GDS score).  Both cognitive groups were found to be 
comparable in terms of education and ethnicity. Differences were noted, however in 
terms of age [F(1, 58) = 6.3, p < .05] and gender (x2 = 6.10, p < .05) among the two 
cognitive comparison groups.  The MCI group was older than the intact group and the 
intact group consisted of more females than males.  Those in the MCI group also 
reported more symptoms on the GDS than those of the intact group [F(1, 44) = 4.70, p 
< .05].  See Table 1 for a summary of cognitive group characteristics and differences. 
Given the significant group difference for age, a one-way covariate model 
(ANCOVA) will be used to statistically control for age in the analyses of the CSMS 
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performance scores among the two cognitive groups.   
3 Age Groups in the Intact sample 
Research on aging described in the text by Moody (1998) uses the following age 
categorizations to classify older participants: “Young-old” is used to characterize 
participants from ages 65-74; “old-old” characterizes participants in age from 75  to 
84; and “oldest-old” is used  to designate those participants aged 85 years of age and 
over.  Previous pilot studies (Price, et. al, 1999; Lamar, et. al, 1998) using the CSMS 
have also used this categorization to examine age differences.  For the purpose of this 
study and to allow for relatively homogeneous group sizes, the youngest old-group age 
limit was adapted and extended to 79.  The age groups listed below are a subsample of 
the participants classified as having MMSE scores of 27 or greater and will serve as 
the ‘normative’ age comparison groups.  See Table 2 for a summary of all age group 
characteristics and differences. 
Young-Old.  The participants in this group consist of 17 older adults, ranging in 
age from 72 to 79. (M = 77.41;  SD = 1.91).   The mean educational level for this 
group was 14.94 (SD = 2.41) and values ranged from 10 to 20 years.  Most of the 
participants (88.2%) had been educated beyond high school.  Fifteen participants 
(88.2%) were female and only two (11.8%) were male.  In terms of ethnicity, all 
participants in this group were Caucasian.  The mean MMSE score for this group was 
28.88 (SD = .99) and scores ranged from 27 – 30.  The mean GDS score for this group 
was .82 (SD = 1.02) and scores ranged from 0 – 2. 
Old-Old.  The participants in this group consist of 15 older adults, ranging in age 
from 80 to 84. (M = 82.20;  SD = 1.42).   The mean educational level for this group 
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was 15.36 (SD = 2.68) and values ranged from 11 to 19 years.  Most of the 
participants (78.6%) were educated beyond high school.  Data regarding education 
was missing for one participant.  Nine participants (60%) were female and six (40%) 
were male.  In terms of ethnicity, all participants in this group were Caucasian.  The 
mean MMSE score for this group was 28.67 (SD = .90) and scores ranged from 27 – 
30.  Thirteen of the 15 participants in the group were administered the GDS.  The 
mean GDS score was 2.15 (SD = 2.76) and scores ranged from 0 – 8. 
 Oldest-Old.  The participants in this group consist of 14 older adults, ranging in 
age from 85 to 95. (M = 88.64;  SD = 2.95).   Although most of the participants 
(76.9%) had been educated beyond high school, their educational levels ranged from 8 
to 18 years (M = 14.42;  SD = 2.86).   All participants in this group were female, and 
regarding ethnicity, thirteen were Caucasian (92.9%) and one was African American 
(7.1%). The mean MMSE score for this group was 28.21 (SD = .98) and scores ranged 
from 27 – 30.  Only nine of the fourteen participants in this group were administered 
the GDS.  The mean GDS score was 3.11 (SD = 3.02) and scores ranged from 0 – 8. 
A Pearson Chi-square was used to examine group differences among the 
categorical demographic data (gender & ethnicity) while univariate one-way 
ANOVAs were used analyze group differences among the continuous variables 
(education, MMSE score, and GDS score).  All age groups were found to be 
comparable in terms of education, ethnicity and MMSE score. Differences were noted, 
however in terms of gender (x2 = 8.6, p < .05) and GDS score .  There were more 
females than males in all three age groups.  In addition, Tukey Post-hoc analysis of the 
GDS indicated those in the oldest-old age group endorsed more symptoms than those 
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of the youngest group [F(2, 36) = 3.31, p < .05].  Despite the difference in GDS scores 
among the groups, participants in all groups were considered free from a significant 
level of clinical depression.  See table 2 for a summary of age group characteristics 
and differences. 
Materials 
Cognitive Screening for Medication Self-Management (CSMS) 
The Cognitive Screening for Medication Self Management (Spiers, 1994) is an 
assessment measure which incorporates 8 functional tasks specifically designed to 
assess the individual motor, sensory and cognitive processes that are believed to be 
associated with medication adherence and management in the elderly.  Although there 
are 13 tasks listed on the protocol forms for the CSMS, the test will be described 
according to the eight constructs that were discussed in the literature review.  Specific 
hypotheses regarding each of the constructs will be described in the analyses section. 
Sensorimotor Ability 
The CSMS involves a task of sensorimotor ability and manual dexterity.  This 
task requires participants to physically open three various types of medication 
containers.  These include a small flip top container, a small child resistant container 
and a medium screw top vial.  Each of the three containers are presented sequentially, 
one at a time for the participant to open.  For each of the three items of this task, a 
correct response is scored 1 while a score of 0 indicates an inability to open the 
container.  In addition, a total number of correct responses is also recorded. 
Visuosensory Ability  
The CSMS involves two tasks involving visuosensory ability.  One of the CSMS 
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involves visual acuity and label reading while the other involves the differentiation of 
various color medication tablets.  For the label reading task, the participant is asked to 
read aloud, medication information on 9 individual index cards.  Each card  depicts 
medication labels of various sized fonts ranging from 5 to 16 points. Cards are 
presented sequentially from the largest to the smallest font type.  The score recorded is 
for the smallest font that the participant was able to read.  Participants received a score 
of 1 if they were able to read down to the smallest font (five point), a score of 2 for the 
six point font, a score of 3 for the seven point font, a score of 4 for the eight point font, 
5 for the nine point, 6 for the ten point, 7 for the twelve point, 8 for the fourteen point 
and a score of 9 if they were only able to read the largest font which was sixteen 
points. 
In the color differentiation task, the participant is shown five photographs, each 
showing a pair of pills. The subject is shown one photo at a time, and is asked to 
report if the pair of pills in the photo are the same color or different.  If any of the first 
five items are reported incorrectly, the participant is administered a second trial of five 
more photographed pairs.  As a result of an anomaly in one of the photograph stimulus 
cards (which was identified in a previous analysis unrelated to this study), which 
compromises the internal validity of the study, scores from this subtest are excluded 
from all analyses in this research. 
Clock Reading/Telling Time 
The CSMS includes a task which involves telling time.  This task consists of 
images of four clocks, each on 4 x 6 index cards.  A clock image on each card depicts 
a different time (e.g. 3:10, 7:45, 8:55, 4:25) and the participant must verbalize the time 
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shown on each.  A score of 1 is given for a correct response while a score of 0 is given 
for an incorrect response.  Total number correct score is also recorded. 
Calculational Ability 
The CSMS involves a task which requires the processing of two dosage 
calculations.  Two index cards, each with dosage calculation instructions and 
representations of pills are presented to the subject.  The examiner asks the participant 
to read the cards aloud, and to calculate and report the answer.  Correct responses are 
scored 1 while incorrect responses are given a score of 0.  A total number correct score 
is also recorded. 
Prospective Memory 
The CSMS includes a Prospective Memory Task.  This task involves the ability 
of the medication user to repeat and understand an initial set of instructions about a 
medication which requires them, upon a future behavioral cue from the examiner, to 
take a pill out of the container and hand it to the examiner.   In this task, the subject is 
shown a small flip-top bottle with pills inside. The examiner instructs the subject in 
the following manner:  “In a little while, I’m going to hand you this pill bottle to try to 
open.  I want you to remember to do something.  When I hand you this bottle, I want 
you to take one pill out of the container and give it to me.  Please repeat the 
instructions back to me.”  If the participant correctly repeats the instructions, a score 
of 1 is recorded.  If not, a score of 2 is recorded and the instruction is repeated until the 
participant can repeat it correctly. Under this circumstance, the number of trials 
required for correct repetition by the participant is also recorded. 
During later administration of the bottle opening task, the examiner hands the 
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subject the small flip-top pill bottle which serves as a cue for the subject to respond 
according to the earlier presented instruction.   Participants received a score of 2 if 
they completed the required action indicating they remembered the earlier instruction 
from Task 1.  They received a score of 1 if they reported they knew they were 
supposed to respond but could not recall exactly how.  They also received a score of 1 
if they responded correctly upon a verbal cue from the examiner (“Was there 
something you were supposed to remember?”). After the verbal cue, if there was still 
no recollection of the earlier instruction, the participants received a score of 0. 
Encoding, Organization & Processing Speed 
The Prescription Memory Test of the CSMS involves tasks of encoding and 
organization of the specific and detailed prescription instructional information which 
is to be later self-initiated and organized in the retrospective memory and recall tasks.  
In this task, the participant is given information on nine 3 ½ x 5 index cards (see 
appendix) regarding a hypothetical prescription and is asked to organize the cards 
however they would like.  To assess the effectiveness of the organizational strategy, 
the actual order and groupings of the cards is also recorded.   
In addition, two scores which involve processing speed are also recorded.  The 
time (in seconds) it takes the participant to organize the cards is recorded as 
organization time while the amount of time (in seconds) it takes the participant to 
review the cards is also recorded as the study time.   
Long-Term Memory and Recall 
  There are a number of subtests of the CSMS which involve retrospective aspects 
of memory and recall.  These tasks, in addition to those which involve the encoding 
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and organizational aspects of the simulated medication information, are also 
components of the Prescription Memory Task.  Once the information is understood, 
encoded, organized, and studied, the participant is asked to recall as much of the 
information as possible. One of the first scores of this task is that of immediate free 
recall.  The participant receives a score for each of the 9 bits of information cards that 
is recalled.  For each of the 9 bits of medication information, participants receive a 
score of 0 if the information is not recalled or incorrect, a score of 1 if the response is 
a close approximation and a score of 2 if the information is recalled correctly. (See 
appendix for detailed scoring criteria).  A total of the 9 scores is also recorded as the 
immediate free recall total score.  The other two tasks of recall occur after a delay of at 
least 15 minutes.  After the delay, the subject is asked to again, recall as much of the 
previously learned medication information as possible.  This is recorded as the delayed 
free-recall score.  The participant again receives a score for each of the 9 bits of 
information as previously described.  A total of the 9 scores is also recorded as the 
delayed free-recall total score.  In the cued-recall task, the examiner provides a cue for 
each of the bits of information which were missed or incorrect during the previous free 
recall task.  For each of the 9 bits of medication information, participants again receive 
the scores as detailed previously. A total of the scores from the items administered is 
recorded as the delayed cued-recall total score. 
Executive Functioning 
The CSMS includes a task which involves the planning aspect of executive 
functioning and involves a hypothetical medication dose planning task.  In this task, 
and after a brief demonstration, the examiner asks the participant to organize two 
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hypothetical medications in a plastic, seven day pill planning organizer, according to 
the printed instructions for each medication.  Scores are recorded for the number 
correct for dose items and the number correct timing items.  There are also total scores 
for each medication in addition to a combined total score which represents the number 
of correct items for both medications.  For the purposes of this study, the combined 
total score which represents the number of correct items for both medications will be 
used in the analysis. 
Mini-Mental State Examination (MMSE) 
The Mini Mental State Examination (MMSE), developed by Folstein, Folstein 
and McHugh (1975) is a brief screening instrument includes assessment of a number 
of cognitive functions and provides a relatively quick estimate of global cognitive 
status.  The MMSE includes brief assessment of memory, attentional and verbal 
comprehension abilities and has been historically used with a variety of clinical 
populations and in a variety of clinical settings (Lezak et al., 2004).  Scores on the 
MMSE can range from 0 to 30 with lower scores indicating a higher level of 
impairment.  A threshold of 23 was previously established by the researchers to 
establish cognitive impairment.  Another method used to describe the severity of 
cognitive impairment categorizes unimpaired cognitive functioning with scores of 24 
to 30, mild cognitive impairment with scores of 18 to 23 and moderate to severe 
cognitive impairment with scores of 0 to 17 (Folstein et al., 1985).   A text by Petersen 
(2003) reports MMSE scores ranging from 25 to 28 to identify mild cognitive 
impairment.   
Normative studies using the MMSE showed lower MMSE scores to be 
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associated with higher age (Bleecker, et al, 1988) and lower education levels (Anthony 
et al., 1982;  Tombaugh & McIntyre, 1992).  In a normative population, the MMSE 
scores were not related to depression severity assessed with the Beck Depression 
Inventory (Bleecker, et al, 1988).  Another study, however, showed a tendency for 
MMSE scores to drop with scores on the Beck Depression Inventory, among patients 
65 years and older (Cavanaugh & Wettstein, 1983). 
 A study by Jones and Gallo (2000), examined the factor structure of MMSE 
item responses in a large sample of older adults.  The results of their factor analysis 
yielded five distinct, though related domains, which were designated as concentration 
or working memory (serial 7's and spelling "world" backwards), language and praxis 
(naming, following commands and construction), orientation, memory (delayed recall 
of three items), and attention span (immediate recall of three items). 
The Mini-Mental State Exam (MMSE) was administered to all participants as an 
overall assessment of general cognitive function.  In the primary sample of 60 
participants, the mean MMSE score was 27.60 (SD = 2.23) with scores ranging from 
20 to 30.  The distribution of scores was somewhat skewed with 16.7 % of the sample 
having a median score of 28 and 33.3% of the sample having a modal score of 29. 
Procedure 
After signing informed consent, participants were screened by the examiner.  
Participants with a history of any hospitalization for a head or brain injury, mental 
illness, a history of drug and/or alcohol abuse and those with uncorrected visual 
deficits were excluded.  Demographic information including age, sex, race and 
educational level of the participants was recorded.  Anonymity of the participants was 
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guaranteed as no names were recorded on the data forms and test protocols.  Each 
participant was given a code number to identify the data. After brief interview and 
recording of demographic information, participants were then administered the 
Cognitive Screening for Medication Self Management (CSMS) and The Mini-Mental 
State Exam (MMSE).   
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RESULTS 
The results of this study have been organized according to the hypotheses and 
will begin with the analysis of the factor structure of the CSMS and convergent and 
discriminative validity issues, followed by two separate group comparisons which 
examine the influence of cognitive status and age on CSMS performance.  Following 
the results of the main hypotheses, another comparative group analysis, using a 
subsample of the oldest-old participants will be presented to examine preliminary 
evidence of the potential interaction effects of age and cognitive status on CSMS 
performance.  The results of the study will conclude with a correlational analysis of 
CSMS performance scores to demographic variables and an analysis of the reliability 
(internal consistency) and item difficulty indices of the appropriate CSMS scales. 
All statistical analyses were conducted using the Statistical Package for the 
Social Sciences - version 13. (SPSS Inc, Chicago, IL).  The level of significance for all 
statistical analyses of this study was p < .05. 
HYPOTHESIS 1: Scores from all four CSMS memory tasks and the dose 
calculation task were predicted to form a unified cognitive component related to 
memory and calculational ability while the dose planning task was predicted to form a 
single cognitive component related to the planning and organizational aspects of 
executive function ability.  The scores for study time and arrangement time were 
predicted to comprise a single component of processing speed.  Label reading and 
clock reading were predicted to comprise a visuosensory component and the bottle 
opening task was predicted to form a sensoriomotor component.  
To examine aspects of construct validity of the CSMS subtests, an exploratory 
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principal components analysis was first conducted.  The initial analysis used the 
eleven total scores from the CSMS (bottle opening, label reading, clock reading, dose 
calculations, arrangement time, study time, immediate recall, delayed, recall, cued 
recall, prospective memory and dose planning).  See Table 3 for a  summary of task 
score performance of the sample.  This initial analysis extracted four factors with 
Eigenvalues (variances of the factors) greater than 1 and this four factor solution 
accounted for 71.68% of the variance of the observed variables. To better differentiate 
the factors and facilitate a theoretical interpretation of the factors, the factor structure 
was then rotated using a varimax orthogonal rotation procedure as described by 
Norusis (2005). 
The rotated four-factor structure yielded a primary factor which accounted for 
36.65% of the total variance.  This main loadings on this factor consisted of the three 
memory scores which had the highest loadings [delayed recall (.865), immediate recall 
(.829) cued recall (.809)], in addition to the dose planning task score (.752) and the 
dose calculation score (.723).  Factor two accounted for 13.72% of the total variance 
and the highest loadings consisted of the scores for arrangement time (.812), visual 
acuity (.718) and study time (.559).   Factor three accounted for 11% of the total 
variance and was relatively well differentiated.  The highest loadings consisted of the 
scores for clock reading (.849) and prospective memory (-.598).  Although the score 
for prospective memory loaded the highest on this factor, that loading was also 
somewhat split with the first factor (.500) of memory and organization.  The fourth 
factor was also well differentiated and accounted for 10.31% of the total variance and 
the highest loading was the score for the bottle opening (.949). 
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Although, an initial principal components analysis helps statistically determine 
how many components best describe or adequately represent the data being examined, 
Norusis (2005) underscores the need to consider and evaluate several factor solutions 
to determine which one most adequately describes the data and which is most 
consistent with the theoretical components being represented.  As a result, another 
principal components analysis was conducted using a five factor solution as outlined 
in the hypothesis.  To better differentiate the factors and facilitate a theoretical 
interpretation of the factors, the factor structure was then rotated using a varimax 
orthogonal rotation procedure as described by Norusis (2005).  This analysis again 
used the eleven total scores from the CSMS (bottle opening, label reading, clock 
reading, dose calculations, arrangement time, study time, immediate recall, delayed, 
recall, cued recall, prospective memory and dose planning).   
The five factor solution accounted for 78.69% of the total variance of the CSMS 
scores (see Table 4) and loaded the scores for the primary component in agreement 
with only some of the predictions.  See Table 5.   
The main loadings on the primary factor consisted of the three retrospective 
memory scores which had the highest loadings [delayed recall (.851), immediate recall 
(.807) cued recall (.806)], and the dose calculation score (.728).  Contrary to the 
prediction, the dose planning task score (.759) also emerged on this primary cognitive 
component.  The prediction regarding the prospective memory score was also not 
supported.  Although it loaded somewhat highly on this factor (-562), the prospective 
memory score did not have its highest loading on this factor.  As a result of these 
loadings, and for practical descriptive purposes, factor one will be designated as a 
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memory and organization factor. 
As predicted, both scores from the processing speed tasks comprised their own 
component.  Factor two accounted for 13.72% of the total variance.   The study time 
score loaded the highest (.842) and was followed by the loading for arrangement time 
(.744).   Since the two highest loadings for the CSMS scales of processing speed were 
on this component, factor two was designated as a component of processing speed.  
Contrary to the prediction, the clock reading score did not load with the label 
reading score.  Although clock reading did have the highest loading on factor three 
(.897), it shared a substantial portion of the variance of factor three with the 
prospective memory score (-562).  While the score for prospective memory loaded the 
highest on this factor, the variance for this variable was also somewhat split with the 
first factor (.521) as described earlier.  Factor three accounted for 11% of the total 
variance.  Since this factor may involve two forms of recognition, factor three will be 
designated as a recognition factor and will be discussed in further detail in the 
discussion section. 
As predicted, the bottle opening task comprised its own sensorimotor factor.  
Bottle opening loaded the highest on the fourth factor (.954).  This component was 
well differentiated and accounted for 10.31% of the total variance.   
Contrary to the prediction, the clock reading task was not loaded with the label 
reading task.  Instead the label reading task comprised its own visuosensory 
component.  Label reading loaded highly on the fifth component (.948).  It was also 
well differentiated and accounted for 7% of the total variance.  The fourth and fifth 
factors respectively comprised distinct sensorimotor and visuosensory components.   
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 In summary, for Hypothesis 1, some of the predictions regarding the factor 
structure of the CSMS were supported.  Consistent with the predictions, the study time 
and arrangement times emerged as unified component of processing speed while bottle 
opening emerged as a well differentiated sensorimotor component. 
Contrary to the predictions, dose planning emerged on the primary cognitive 
component along with the three retrospective memory tasks and the dose calculation 
task while the clock reading and the prospective memory tasks demonstrated an 
unexpected convergent relationship.  Also contrary to the prediction, a convergent 
relationship between the label reading and clock reading tasks was not supported. 
 HYPOTHESIS 2:  The CSMS scores which were purported to be primarily 
cognitive in nature were predicted to show correlations of moderate strength with the 
MMSE total score.  The cognitive scores of the CSMS which were predicted to be 
associated with the MMSE score are the dose calculation score, the two processing 
speed scores (study time and arrangement time), the dose planning score and all of the 
memory scores (immediate recall, delayed recall, cued recall and prospective 
memory). 
No significant correlations between the MMSE and the CSMS bottle opening, 
label reading or clock reading scores were predicted.  
 To examine the convergent and discriminative relationship of each of the CSMS 
scores with global cognitive functioning, one-tailed Pearson-r correlational 
coefficients were generated between the MMSE and all of the CSMS total 
performance scores.  The alpha level was set at .05 to identify significant 
relationships. 
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As predicted, all the cognitive tasks of the CMSM demonstrated significant 
associations with the MMSE score.  See Table 6.  Virtually all the scores 
demonstrated significant associations of moderate strength with the MMSE score.  
These included all the CSMS memory scores (immediate recall r = .56, delayed recall 
r = .48 and cued recall r = .43; p < .01) and the dose planning score (r = .68, p < .01).  
Although the calculational score demonstrated a significant association with the 
MMSE score, it was weaker than predicted (r = .33, p< .01).  Higher scores on the 
MMSE were associated with better performance on all three CSMS memory tasks, the 
dose planning task and the calculation task.   
As predicted, both the study time and arrangement time scores also demonstrated 
significant associations with the MMSE score. In support of the hypothesis, the 
association of the study time score with the MMSE score was moderate in strength (r 
= -.428, p < .01) while the strength of the association of the arrangement time score 
with the MMSE was somewhat weaker than predicted (r = -.331, p < .01).  Higher 
scores on the MMSE were associated with shorter arrangement time and study time 
scores. 
Consistent with the hypothesis, no significant associations between the MMSE 
score and the clock reading score (r = .029, p  > .05), bottle opening score (r = -.087, p  
> .05) or label reading score (r = -.176, p  > .05) were observed.   
 HYPOTHESIS 3:  In a comparison of two groups, differentiated by cognitive 
status as assessed using the MMSE, the intact group was predicted to demonstrate 
better performance for the CSMS cognitive tasks (dose calculations, dose planning, 
immediate recall, delayed recall, cued recall and prospective memory) and processing 
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speed tasks (study time and arrangement time) than those of the MCI group.  
  No cognitive group performance effect on the label reading, bottle opening or 
clock reading tasks was predicted.  
  Since an age difference was demonstrated among the two cognitive status 
groups, and the MCI group was found to be older, a one-way analysis of covariance 
(ANCOVA) was used to test for performance differences among the two cognitive 
status groups on each of the CSMS performance scores.   
  Of the predictions regarding the cognitive tasks of the CSMS, all but one were 
supported.  See Table 7.  The results of the ANCOVAs demonstrated a similar pattern 
of significance among the scores for all of the memory tasks, the dose planning task 
and both processing speed scores of the CSMS.   
Performance on the CSMS tasks of immediate recall [F(2, 59) = 5.57, p < .01], 
delayed recall [F(2, 59) = 4.62, p < .05] , cued recall [F(2, 53) = 6.04, p < .01], 
prospective memory [F(2, 58) =  4.06, p < .05], dose planning [F(2, 56) = 18.94, p < 
.01], study time [F(2, 55) = 4.56, p < .05] and arrangement time [F(2, 58) = 5.03, p < 
.05] was differentiated among the two cognitive status groups.   In support of 
hypothesis 3, those in the intact group performed better on the memory and planning 
tasks than those in the MCI group. The intact group also took less time to study and to 
arrange the medication information than that of the MCI group. Contrary to the 
hypothesis regarding the cognitive tasks, the score for dose calculations [F(2, 58) = 
2.48] was not differentiated between the two cognitive groups.  The effect however, 
showed a trend that approached significance (p = .09).  
Consistent with the predictions of the non-cognitive and sensory tasks, the 
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results not demonstrate a significant cognitive group effect for clock reading [F(2, 45) 
= .436, p >.05] or bottle opening [F(2, 49) = 5.28, p >.05].  See Table 8.  Contrary to 
the prediction however, a significant difference was demonstrated for the label reading 
score [F(2, 58) = 5.91, p < .01].   
Despite the statistical control for age between the two cognitive status groups, 
the MCI group performed more poorly than the intact group on the label reading task. 
HYPOTHESIS 4:  In a comparison of CSMS performance among three different 
age groups, differences among all three groups are predicted for all the CSMS task 
scores (including dose calculations, dose planning and all of the memory tasks 
(immediate recall, delayed recall, cued recall and prospective memory) except for 
clock reading.  Those in the younger groups will demonstrate better performance on 
the cognitive, sensory and processing speed tasks of the CSMS than those in the older 
groups. 
 To examine the effects of age group on each of the CSMS components, a one-
way analysis of variance was used to test for performance differences among the three 
intact age-groups.  The Tukey post-hoc procedure was used to further delineate any 
significant differences between the age groups. 
Contrary to the hypotheses regarding the effect of age on memory, organization 
and calculational abilities, only one of the CSMS scores (Prospective memory) was 
significantly differentiated among the three intact age groups.  See Table 9. 
Results of the one-way ANOVA yielded no significant effects for age group for 
scores of immediate recall [F(2, 42) = 2.13, p > .05], delayed recall [F(2, 42) = 2.64, p 
> .05] , cued recall [F(2, 36) = 2.19, p > .05], dose planning [F(2, 40) = 1.00, p > .05] 
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or dose calculations [F(2, 43) = 1.73, p > .05].  In partial support of Hypothesis 4, a 
significant age group effect for the prospective memory score was demonstrated [F(2, 
43) = 5.96, p < .01].  The Tukey post-hoc test indicated that prospective memory 
scores of the oldest-old group were significantly different from both the young-old and 
the old-old groups, however performance between the two youngest groups was 
comparable. The oldest-old participants performed worse on prospective memory than 
those in both younger groups.  See Table 10.   
The predictions regarding the CSMS processing speed tasks were only partially 
supported.  A significant age group effect was only demonstrated for the arrangement 
time score [F(2, 42) = 4.50, p < .05].  Tukey post-hoc analysis indicated the significant 
difference between only the youngest-old group and the old-old group.  Participants in 
the youngest-old group used less time to arrange the cards than those in the old-old 
group.  Interestingly, and contrary to the prediction, there was no significant 
performance difference demonstrated between the oldest-old and the youngest-old.  
Also contrary to the prediction, no significant age effect for the study time score [F(2, 
41) = .726, p > .05] was demonstrated. Participants in all three age groups used 
comparable times to study the medication information.  
The predictions regarding age differences and both sensory tasks of the CSMS 
were not supported.   See Table 10.  Participants in all three age groups performed 
comparably on the CSMS tasks of bottle opening [F(2, 36) = .190, p > .05] and label 
reading [F(2, 42) = 1.21, p > .05].   Although there was a trend for the visual acuity 
score to worsen with each successive age group, the differences were not significant.   
The hypothesis regarding the clock reading task score was supported.  As 
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predicted, there was no significant age group effect demonstrated for the clock reading 
score [F(2, 36) = .839, p > .05].  The clock reading performance of those in all three 
groups was comparable.  
Interaction Effects on CSMS Performance 
Although ideally, a 2 (cognitive group) x 3 (age group) ANOVA was preferred 
to examine potential interaction effects of both age and cognitive status on the 
performance scores of the CSMS, the limitations in the number of subjects in the 
database did not allow this type of analysis.  As a result, a comparative analysis of 
performance among the participants classified as cognitively intact and mildy 
impaired (using the MMSE criterion which was previously described) was conducted 
using a small sample consisting of the oldest-old participants. See Table 10.  
A Pearson Chi-square was used to examine group differences among the 
categorical demographic data (gender & ethnicity) while univariate one-way 
ANOVAs were used to analyze group differences among the continuous variables 
(education, MMSE score, and GDS score).  Both cognitive groups were found to be 
comparable in terms of age, education, ethnicity and GDS score.   Differences were 
noted in terms of MMSE score [F(1, 22) = 76.20, p < .01), and gender (x2 = 6.10, p < 
.05) among the two cognitive groups.  The intact group had higher MMSE scores than 
the MCI group and the intact group consisted of more females than males. See table 
11 for a summary of cognitive group characteristics and differences. 
In the performance comparison of participants in the oldest-old age group, the 
only CSMS performance scores to differentiate the two cognitive groups were from 
the tasks of immediate recall [F(1, 21) = 7.24, p < .05], cued recall [F(1, 19) = 8.73, p 
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< .01] and dose planning  [F(1, 19) = 18.22, p < .01].  See Table 12. 
Among the oldest-old, participants in the intact group performed better than 
those in the MCI group on the immediate recall, cued recall and dose planning tasks.  
While those in the intact group demonstrated a trend for better performance on the 
delayed recall task as compared to the MCI group, the difference only approached 
significance [F(1, 21) = 7.24, p = .07].  No significant cognitive status group effect 
was demonstrated on the score for the dose calculations [F(1, 20) = .004, p  > .05].  
Performance on the dose calculation task among participants in the intact and 
comparison groups was comparable.  
In addition, no significant differences were demonstrated for either of the 
processing speed scores which included study time [F(1, 18) = .724, p > .05] and 
arrangement time [F(1, 21) = .696, p > .05]  See Table 13 for a summary of these 
performance results.   Among the oldest-old, the speed of processing to study and to 
arrange the medication information was comparable for both cognitive groups.  
No significant differences were demonstrated for the clock reading score [F(1, 
12) = 1.54, p > .05], the prospective memory score [F(1, 22) = .056, p > .05], and the 
two sensory component scores including bottle opening [F(1, 14) = .144, p > .05] and 
label reading  [F(1, 21) = .047, p > .05].  See Table 13. 
Among the oldest-old, the scores for prospective memory, clock reading and 
both sensory components were comparable between the two cognitive groups.  In 
summary, in a subsample of the oldest-old participants, only 2 of the 4 CSMS memory 
task scores differentiated  performance among cognitively intact and mildly impaired 
cognitive status groups.   Performance among those in both cognitive groups was 
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comparable on the CSMS tasks of prospective memory, processing speed, clock 
reading, and visuosensory and sensorimotor abilities. 
Relationship of Demographic Variables to CSMS Performance  
Although it was not a primary focus of the study and there were no group 
differences on educational level observed, an analysis of the correlational matrix of the 
CSMS performance scores demonstrated some significant correlations with 
educational level.    A near moderate strength association with education was 
demonstrated with the dose calculation score (r = .38, p < .01), while weaker 
associations with educational level were demonstrated with the clock reading (r = .31, 
p < .05), study time (r = -.30, p < .05), immediate recall (r = .29, p < .05) and dose 
planning scores (r = .27, p < .05).   
Higher levels of education were associated with better performance on the dose 
calculation, clock reading, immediate recall and dose planning tasks.  In addition, 
higher levels of education were associated with quicker study time scores. 
With the exception of the cued recall task total score (r = .36, p < .01), gender 
was not significantly correlated with any of the other CSMS task scores. 
Relationship of CSMS Performance and the Geriatric Depression Scale Score 
The Geriatric Depression Scale (GDS), developed by Yesavage et al., (1983) 
was designed as a screening instrument to assess the presence and severity of 
depressive symptoms in an older population.  The screening instrument consists of 30 
yes-no questions involving cognitive complaints, motivation, self image, future/past 
orientation, losses, agitation, obsessive traits and general mood.  A shorter version of 
the GDS using only 15 items was subsequently developed (Sheikh & Yesavage ,1986;  
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Yesavage, 1988; Burke et al., 1991).   
Although it was not a primary focus of this study, the short version of the 
Geriatric Depression Scale (GDS) was administered to forty-six  of the participants in 
this study.  Scores ranged from zero to eight (M = 2.13;  SD = 2.58).  Nineteen 
(41.3%) of those who were assessed on this scale did not endorse any items on the 
GDS while twenty-seven (58.7%) did endorse some items. Normative data outlined by 
Yesavage et al., (1983) suggest normal scores from 0-10 with scores of 11 or greater 
as an indication of depression.   Despite the fact that some participants in this study 
did endorse items on the scale, according to this criterion, all participants in this study 
who were administered the GDS, were still considered free from clinical depression. 
An analysis of the correlational matrix of the CSMS performance scores 
demonstrated some significant correlations with the GDS score.  The GDS score 
demonstrated mild to moderate but significant associations with the dose planning 
score (r =  -.36, p < .01), arrangement time score (r = .39, p < .01) and the dose 
calculation score (r =  -.40, p < .01) and a weaker but still significant association with 
the cued recall score (r =  -.31, p < .05).  Higher scores on the GDS were associated 
with lower scores on the dose planning, dose calculation and cued memory tasks. 
Higher scores on the GDS were also associated with longer arrangement times.  It is 
important to note that none of the participants in any of the groups demonstrated GDS 
scores which were indicative of a clinical level of depression. 
Internal Consistency & Item Difficulty 
Cronbach’s coefficient alpha was calculated for the individual items of the dose 
calculation, clock reading, bottle opening, and all three memory tasks (immediate 
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recall, delayed recall, and cued recall) of the CSMS as an indicator of internal 
consistency (reliability).  In addition, the Item Difficulty Index was also calculated for 
those items. 
The repetition of the instruction from the Prospective Memory Task is used as a 
screening item to ensure that the initial instruction has been heard. As a result, the item 
difficulty index for this task is also reported 
Dose Calculations 
Cronbach’s Alpha was demonstrated to be .31 for the two dose calculation items. 
See Table 14.  An analysis of the item difficulty index demonstrated the second dose 
calculation item to be a bit more difficult.  Item one yielded an index of .81 while item 
two yielded an index of .68.   
Clock Reading 
Cronbach’s Alpha was demonstrated to be .165 for the four clock reading items.  
See Table 14.  An analysis of item difficulty index for the four clock reading items 
yielded the following results: 
Clocks 1, 3 and 4 yielded item difficulty index scores near 1. The Index score for 
clock 4 was .98 while the index score for clocks 1 and 3 was .96.  These index scores 
indicate most of the clock items were relatively easy to read for most participants.  
Clock 2, however yielded an item difficulty index of only .80, suggesting this item 
was more difficult than the others.  9 of 46 participants were unable to read the time 
on clock 2 and a potential reason will be detailed in the results section of this study. 
Bottle Opening 
The results of performance on the medium screw top bottle demonstrated zero 
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variance and as a result, it was automatically removed from the scale and the 
computation of the Cronbach Alpha coefficient.  Cronbach’s Alpha was demonstrated 
to be -.076 for the three bottle opening items of the CSMS.  See Table 14.   The item 
difficulty index was calculated for each of the three various medication containers and 
yielded the following results:   
The medium screw top bottle was the easiest of the bottle opening items.  It was 
successfully opened by all of 50 participants, yielding a difficulty index of 1. One of 
54 was unable to open the small flip-top container, yielding a difficulty index of .98.  
The child resistant container was the most difficult to open in this sample of older 
adults.  The smallest container was the most difficult to open but was still successfully 
opened by over 85% of the participants in the study.  Six of 56 were unable to open 
the small child resistant container, yielding an index of .89.  See Table 10 for a 
summary of these results. 
Prospective Memory Instruction 
On the prospective memory item which requires the participants to repeat the 
initial prospective memory instruction, 100% of the participants among all age and 
cognitive groups successfully completed it.  See Table 14 for a summary of these 
results. 
Immediate Recall Items 
Cronbach’s Alpha was demonstrated to be .58 for the nine medication 
information card items of the Immediate Free Recall Scale of the CSMS.  See Table 
15.  The item difficulty index was also calculated for each of the 9 cards, and are listed 
in order from easiest to hardest items: Card 8 (“If rash occurs call doctor”; p = .85), 
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card 4 (“Heart Medicine”; p = .83), card 2 (“May cause a rash”; p = .76), card 5 (“May 
cause sleepiness”; p = .75), card 7 (“Cardipol”; p = .73), card 6 (“2 pills before 
breakfast”; p = .66), card 9 (“Take for two weeks”; p = .60), card 3 (“ Do not take with 
food”; p = .58), card 1 (“2 pills before bed”; p = .55).  See Table 14 for a summary of 
these results. 
Delayed Recall Items 
 Cronbach’s Alpha was demonstrated to be .64 for the nine medication 
information card items of the Delayed Free Recall Scale of the CSMS.  See Table 16.  
The item difficulty index was also calculated for each of the 9 cards, and are again 
listed in order from easiest to hardest items: Card 8 (“If rash occurs call doctor”; p = 
.80), card 4 (“Heart Medicine”; p = .67), card 2 (“May cause a rash”; p = .65), card 5 
(“May cause sleepiness”; p = .65), card 3 (“ Do not take with food”; p = .45), card 9 
(“Take for two weeks”; p = .43), card 7 (“Cardipol”; p = .33), card 1 (“2 pills before 
bed”; p = .33) and card 6 (“2 pills before breakfast”; p = .27).  See Table 15 for a 
summary of these results. 
Cued Recall Items 
Cronbach’s Alpha was demonstrated to be .83 for the nine medication 
information card items of the Cued Recall Scale of the CSMS. See Table 17.   The 
item difficulty index was also calculated for each of the 9 cards, and are again listed in 
order from easiest to hardest items: Card 8 (“If rash occurs call doctor”; p = .81), card 
2 (“May cause a rash”; p = .73), card 4 (“Heart Medicine”; p = .71), card 5 (“May 
cause sleepiness”; p = .52), card 9 (“Take for two weeks”; p = .42), card 1 (“2 pills 
before bed”; p = .42), card 3 (“ Do not take with food”; p = .36), card 6 (“2 pills before 
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breakfast”; p = .35) and card 7 (“Cardipol”; p = .27). See Table 16 for a summary of 
these results. 
The results of the internal consistency calculations for the clock reading, bottle 
opening and dose calculation tasks demonstrated Cronbach alpha coefficients which 
ranged from .08 to .31.  While these values hardly indicate adequate levels of internal 
consistency, they are directly attributable to the small number of items and the low 
level of performance variance on each of those scales.  As a result, an examination of 
internal consistency for these scales of the CSMS does not yield very meaningful or 
useful results. 
The examination of Cronbach's Alpha for the CSMS memory scales however, 
yielded more adequate levels of internal consistency.  While these memory scales have 
more items than the previously mentioned scales with low internal consistency, 
reliability coefficients for the memory scales ranged from .58 to .84.  These findings 
suggest psychometric homogeneity of the items of all three CSMS memory scales. 
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 DISCUSSION 
  The preliminary performance data utilizing the Cognitive Screening for 
Medication Self-Management (CSMS) in a sample of independently functioning older 
adults appears to support the construct validity of the measure in identifying the 
specific cognitive and sensory components involved with understanding, organizing 
and executing a medication routine.  The study also provides useful information 
regarding the psychometric nature of the test and more specifically, to the convergent 
and discriminant relationship of the CSMS components to global cognitive ability.   
Additionally, and in further support of the construct validity of the CSMS in an 
older adult population, comparisions of group performance using the CSMS have 
shown utility in identifying the influence of age and the effect of mild cognitive 
impairment on the performance of tasks related to medication taking. 
The discussion of the findings of this study are organized according to the main 
hypotheses followed by a summary of internal consistency and item difficulty 
findings.  The discussion of this study will conclude with a summary of the strengths 
and limitations of the study and suggestions for future research to improve the test. 
HYPOTHESIS 1: Scores from all four CSMS memory tasks and the dose 
calculation task were predicted to form a unified cognitive component related to 
memory and calculational ability while the dose planning task was predicted to form a 
single cognitive component related to the planning and organizational aspects of 
executive function ability.  The scores for study time and arrangement time were 
predicted to comprise a single component of processing speed.  Label reading and 
clock reading were predicted to comprise a visuosensory component and the bottle 
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opening task was predicted to form a sensoriomotor component.  
 The five factor solution loaded some scores for the primary component contrary 
to the predictions.  Although the primary cognitive factor of the CSMS comprised a 
memory and organization component, it was comprised of only three of the four 
predicted memory tasks.  While all three retrospective memory tasks were included in 
this component, the prospective memory task was only partially included. Contrary to 
the prediction, the prospective memory factor loading was split between this primary 
factor and another factor which loaded the highest with clock reading.  Also contrary 
to the prediction, the dose planning task loaded on this factor. 
These findings suggest that the primary component of the CSMS is cognitive in 
nature and involves convergent aspects of retrospective long-term memory, 
calculational ability and the planning/organizational aspects of executive functioning 
skills.  While there is a body of research which supports both discriminant and 
convergent relationships between executive functioning and memory skills, it seems 
there is more convergence with these processes in their relationship to medication 
taking skills.  The prospective memory task was not well-differentiated on the primary 
cognitive component, and this finding suggests both a convergent and discriminant 
psychometric property of the prospective memory task.  The prospective memory task 
score shared an almost equal proportion of variance with both cognitive and non-
cognitive components.  Regardless of the discriminant and convergent relationships,  
retrospective long-term memory, calculational and planning/organizational skills, in 
addition to an aspect of prospective memory function, appear to be the most 
fundamental elements involved in the process in which older adults understand, 
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organize and execute a medication routine. 
As predicted, the scores from the study time and arrangement time tasks 
demonstrated a convergent relationship and comprised their own component of 
processing speed.  In addition, both scores were well differentiated from the others on 
this factor, which provide support for the discriminative construct validity of the 
processing speed tasks in relation to the other cognitive and sensory tasks of the 
CSMS.  Although processing abilities such as study time and arrangement time may 
both be important cognitive components of medication taking, together, they share 
enough overlapping variance to comprise their own cognitive component, distinct 
from the other cognitive, sensorimotor and visuosensory components of the CSMS.  
While this component comprised the next largest proportion of explained variance, 
this finding suggests that tasks of processing speed are also highly relevant processes 
involved in medication taking. 
Contrary to the prediction, the clock reading score did not emerge with label 
reading as a component of visuosensory ability, but rather unexpectedly with the 
prospective memory task.  This finding regarding clock reading in the five-factor 
structure of the CSMS  suggests both a convergent and discriminant psychometric 
property.   To support a discriminant property, clock reading was well differentiated 
from the other cognitive and sensory factors.  Since clock reading also shared a 
substantial portion of the variance of its component with prospective memory, a 
convergent psychometric property with an aspect of prospective memory ability is also 
suggested. 
  An examination of the actual nature of the CSMS clock reading and prospective 
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memory tasks may suggest that their communality may be in part, related to two, 
somewhat different forms of recognition.  The ability to tell the time from a clock 
requires the understanding of the concept of time, in addition to some basic, but 
specific abilities which allow one to recognize the numbers and to understand the 
orientation of the hands on the clock.  Research suggests that clock reading is an 
overlearned task for most people, so the noted requisite subcomponents may occur, for 
most, without any significant amount of effortful cognitive processing.  As a result of 
this most rapid processing, the final output may be identified as a simple form of 
recognition of the time, which requires very little or no effortful cognitive processing. 
  The prospective memory task score may also represent a slightly different form 
of recognition, but a form of recognition nonetheless.  In the CSMS task of 
prospective memory, the correct response is based on the successful completion of two 
components.  The first component required to correctly respond to the prospective 
memory item involves the recognition of the behavioral cue stimulus (e.g. the 
examiner handing the participant the specific medication vial), while the second 
involves a behavioral response (e.g the participant taking out one pill out of the 
container and handing it to the examiner).  The responses are based on that recognition 
or memory of the previously detailed instruction.  While the recognition portion of the 
prospective memory task may be represented by the score's variance on the third 
factor, a portion of the memory component variance along with possibly, another 
portion which represents the initiation of behavior, is what may be represented by the 
variance of this score on the first cognitive component involving memory, planning 
and organizational ability. 
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  It seems that the subcomponents of the prospective memory task involve 
psychometric elements from the first fundamental cognitive component suggesting a 
convergent relationship with retrospective long term memory, recall and potentially, 
the initiation, planning and organizational aspects of executive functioning abilities.  
In addition, another subcomponent of prospective memory appears to involve a 
psychometric component which suggests a relationship of the prospective memory 
task with general recognition ability. 
As predicted, the bottle opening task was well differentiated from the other 
components and comprised a distinct sensorimotor component. While the predicted 
convergent relationship of label reading and clock reading was not supported, label 
reading did emerge as its own well differentiated visuosensory component.  These 
findings suggest a discriminant relationship of the sensory tasks to each other and to 
the other cognitive components of the CSMS. 
 In summary of Hypothesis 1, the analysis of the factor structure of the CSMS 
provides further evidence to support the construct validity of the measure.  The 
findings suggest that the CSMS is comprised of 5 primary cognitive and sensory 
components.  While the first two components are cognitive in nature, the third appears 
to be comprised of a cognitive and non-cognitive element.  The remaining components 
appear largely related to distinct sensorimotor and visuosensory functions.  The results 
of the factor structure may have some practical implications for the future scoring of 
the CSMS which are further discussed in the concluding portion of this study.  
HYPOTHESIS 2:  The CSMS scores which were purported to be primarily 
cognitive in nature were predicted to show correlations of moderate strength with the 
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MMSE total score.  The cognitive scores of the CSMS which were predicted to be 
associated with the MMSE score are the dose calculation score, the two processing 
speed scores (study time and arrangement time), the dose planning score and all of the 
memory scores (immediate recall, delayed recall, cued recall and prospective 
memory). 
No significant correlations between the MMSE and the CSMS bottle opening, 
label reading or clock reading scores were predicted.  
As predicted, all of the purported cognitive and processing speed tasks of the 
CSMS demonstrated significant associations with the MMSE score and virtually all 
the associations were of moderate magnitude.  In support of the hypothesis, a 
convergent relationship was demonstrated between global cognitive functioning and 
all of the CSMS memory scores and both tasks of processing speed.  The magnitude of 
the relationships of global cognitive functioning with the calculational and 
arrangement time tasks, however, were weaker than predicted.   Higher scores on the 
MMSE were associated with better performance on all three CSMS memory tasks, the 
dose planning task and the calculation task while higher scores on the MMSE were 
associated with shorter arrangement time and study time scores.  These finding 
support the convergent validity of these CSMS scales in relation to general cognitive 
ability.  The findings also provide further evidence to support the concurrent criterion-
related and convergent construct validity of the CSMS as a measure which consists of 
various fundamental components which are cognitive in nature. 
Consistent with the hypothesis, no significant associations between the MMSE 
score and the clock reading score, bottle opening score or label reading score were 
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observed.   These findings support the discriminant relationship between the sensory 
aspects of medication taking and global cognitive functioning.  The findings also 
suggest that the sensory components of the CSMS are independent of cognition. 
 In summary of Hypothesis 2, the findings support both discriminant and 
convergent aspects of the construct validity of the CSMS in addition to supporting 
evidence of the criterion related validity of the CSMS tasks in relation to global 
cognitive functioning as assessed with the MMSE.  While the tasks of memory, 
calculations, planning and processing speed appear cognitive in nature, the 
sensorimotor, visuosensory and clock reading tasks appear independent of cognition. 
 HYPOTHESIS 3:  In a comparison of two groups, differentiated by cognitive 
status as assessed using the MMSE, the intact group was predicted to demonstrate 
better performance for the CSMS cognitive tasks (dose calculations, dose planning, 
immediate recall, delayed recall, cued recall and prospective memory) and processing 
speed tasks (study time and arrangement time) than those of the MCI group.  
  No cognitive group performance effect on the label reading, bottle opening or 
clock reading tasks was predicted.  
  In the analyses examining the effect of cognitive status, all but two of the 
predictions regarding CSMS task performance were supported.  In the analysis of 
performance between participants classified as intact to those of the MCI group, the 
groups were significantly differentiated on all the cognitive scales except for the dose 
calculation task. The intact group performed better on virtually all of the cognitive 
CSMS tasks including all three memory tasks (immediate recall, delayed recall, cued 
recall) and the dose planning task. 
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In addition, the intact group also took less time to study and to arrange the 
medication information than that of the MCI group.  This finding, along with the 
finding that performance on the recall tasks of the intact group was also better, 
suggests an overall better level of efficiency of cognitive processing for this group of 
intact older adults.  The MCI group took longer to arrange the cards, required more 
time to study the cards and also performed less well on the recall tasks.  This suggests 
that those adults in the MCI group demonstrated less efficient cognitive performance 
on the Prescription Memory task of the CSMS. 
These finding suggests that cognitive status, at least as measured by the MMSE, 
is a factor which may influence performance on the primary measures of medication 
management skills involving retrospective memory and recall, prospective memory 
and the planning and organizational aspect of executive functioning.  In addition, 
cognitive status also appears to be a factor which has an influence on the speed and 
possibly the efficiency of processing for medication related information.  The intact 
group was able to study and arrange the medication information more rapidly than 
those which were mildly impaired.  
  Contrary to the prediction, performance on the dose calculation task between the 
two groups demonstrated no significant difference.  This finding may be a result of the 
relative simplicity of the items which comprise the dose calculation scale and the 
relatively mild impairment level of the sample used in this study. An examination of 
the item difficulty index of the dose calculation scale suggests that the participants in 
this study were able to calculate both items with relative ease. 
Consistent with the predictions regarding the non-cognitive and sensory tasks, 
 97
the finding of this study did not demonstrate a significant cognitive group effect for 
clock reading or bottle opening.  This finding lends further evidence to the 
discriminant validity of the CSMS clock reading and bottle opening tasks as being 
skills which are largely independent of cognitive ability. 
Contrary to the prediction however, a significant difference was demonstrated 
for the label reading score. The MCI group demonstrated lower levels of visual acuity 
than the intact group on the label reading task.  While visuosensory ability such label 
reading is purportedly independent of cognition, this finding may represent more of an 
effect related to frailty rather than cognitive dysfunction.    
In summary of Hypothesis 3, the findings of this study suggest that mild 
cognitive impairment may influence a number of skills related to medication taking in 
older adults, despite their living independently within the community.  These skills 
include retrospective long term memory, prospective memory and dose planning.  In 
addition, mild cognitive impairment may also influence the speed of processing of 
medication related information in this population.  While mild cognitive impairment 
may be related in some way to frailty as observed by the difference among the groups 
with label reading, it appears to have no influence on the medication tasks of clock 
reading and bottle opening. 
HYPOTHESIS 4:  In a comparison of CSMS performance among three different 
age groups, differences among all three groups were predicted for all the CSMS task 
scores (including dose calculations, dose planning and all of the memory tasks 
(immediate recall, delayed recall, cued recall and prospective memory) except for 
clock reading.  Those in the younger groups will demonstrate better performance on 
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the cognitive, sensory and processing speed tasks of the CSMS than those in the older 
groups. 
 Contrary to the hypotheses regarding the effect of age on memory, organization 
and calculational abilities, only one of the CSMS scores (Prospective memory) was 
significantly differentiated among the three intact age groups.  No significant effects 
for age group for the CSMS scores of immediate recall, delayed recall, cued recall, 
dose planning or dose calculations were observed. This finding suggests that, at least 
for older adults classified as cognitively intact using the MMSE, age doesn't appear to 
be a factor which significantly influences the CSMS tasks of memory, planning and 
calculational ability.  Whereas a sample reflecting more heterogeneity of age and 
which included adults younger than 72 might have yielded different results, the lack of 
significant findings among the age groups in this sample may be in part, related to the 
fact that the entire sample was comprised of relatively older adults.  Older, 
independently functioning adults from ages 72 to 95 appear to perform comparably on 
medication management tasks involving retrospective memory, calculational and 
planning/organizational abilities.  
In partial support of Hypothesis 4, the performance on the prospective memory 
task between those in the two youngest age groups was comparable while the 
performance of the two older groups differed from each other.  Those in the oldest-old 
group performed the worse on the prospective memory task than those in both younger 
age groups. It seems that even the intact of the oldest-old may be more vulnerable to 
problems of prospective memory.  
In the comparison of intact participants among the three age-groups, the 
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hypothesis regarding the arrangement time score was partially supported. Age 
differences were noted between participants of only the two youngest age groups.  The 
fact that there was no difference between the youngest-old and oldest-old group 
contradicts previous research regarding decreased processing speed and advancing age 
and for this study, the findings seem to be the result of an outlier in the performance 
data for arrangement time which inflated the mean for the middle age group.  If the 
outlier is not responsible for the lack of predicted significance, the finding may 
support evidence of the discriminative validity of the two CSMS tasks of processing 
speed. Further repeat analysis of the data with removal of the outlier subject yielded 
results more consistent with the research.  With the outlier removed, those in the  
youngest age group did process the information significantly faster than those in the 
oldest-old group.   
Furthering potential support for the discriminative construct validity of the two 
CSMS tasks of processing speed and contrary to the hypothesis, no significant age 
effect was demonstrated on the study time score across the three age-groups.  In this 
cognitively intact sample of older independently functioning adults, participants 
among three age groups spent comparable times studying specific medication related 
information. 
The predictions regarding age differences and both sensory tasks of the CSMS 
were not supported.  Cognitively intact older adults among three differing age groups 
appear to perform comparably on the sensory tasks related to medication taking.  
The hypothesis regarding the clock reading task score was supported.  Clock 
reading skills were comparable among those in all three age groups. 
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In summary of Hypothesis 4, it appears that age had an effect on only two of the 
cognitive CSMS tests of medication taking suggesting that older adults across three 
age groups perform comparably on most of the cognitive and sensory tasks related to 
medication taking.  While the two tasks which differentiated the age groups included 
those measuring prospective memory ability and arrangement time, this finding 
suggests that processing speed and prospective memory abilities may be the most 
vulnerable skills of medication taking to decline with advancing age. 
Interaction of Age and Cognitive Status on CSMS Performance 
  In the analyses examining the effect of cognitive status among only the oldest-
old age group, cognitive status differentiated performance on only the immediate 
recall, cued recall and dose planning tasks of the CSMS.  This finding suggests that 
even in the oldest-old, most of the retrospective long term memory and 
planning/organizational tasks are performed better by cognitively intact individuals. 
  Contrary to the previous comparison of the two cognitive groups, in this 
comparison of just the oldest-old, there were no significant differences demonstrated 
between the two cognitive groups for the CSMS task scores of delayed recall, dose 
calculations,  either of the two tasks of processing speed.  This finding suggests that, 
despite having differing cognitive status as assessed with the MMSE, independently 
functioning adults aged 85 and over, seem to show comparable levels of speed of 
processing of medication information.  Whether the lack of significant effect for the 
dose calculation delayed recall, prospective memory and processing speed scores is 
attributable to compromised statistical power (due to the limited sample size) in 
detecting a significant difference, or to distinct discriminative psychometric properties 
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of those tasks themselves, will need to be explored further in a future study utilizing a 
larger sample size. 
  Consistent with the previous comparison of the two cognitive groups, in this 
comparison of the oldest-old,  there were no performance difference demonstrated on 
the non-cognitive CSMS tasks of clock reading, bottle opening or label reading among 
those in the two cognitive status groups.  All of the older adults in this subsample, 
regardless of their cognitive status, performed comparably on the non-cognitive 
medication tasks involving clock reading, sensorimotor and visuosensory abilities. 
  While this pattern of consistency and inconsistency of results when compared to 
the results of the previous cognitive status comparison begins to demonstrate evidence 
regarding the interaction effects of age and cognitive status on performance of specific 
tasks of medication taking, more studies utilizing larger samples are needed to further 
examine these interactions. 
Relationship of Demographic Variables to CSMS Performance 
  Despite the fact there were no educational differences in the any of the cognitive 
or age-groups, educational level was found to be associated with the CSMS 
performance scores of immediate recall, dose calculations, and dose planning.  Higher 
educational levels were associated with better performance on the medication tasks 
involving immediate recall, dose calculations, and dose planning.  As a result of these 
findings and the fact that the sample utilized in the study was relatively well educated, 
further research which further examines the relationship of education on these 
performance variables should be conducted utilizing participants with lower 
educational levels. 
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  While both the CSMS study time and arrangement time scores appear to assess 
processing speed and share much communality, the findings also indicate some 
differences between them.  Study time demonstrated a weak but significant 
relationship with educational level. Lower study times were associated with higher 
levels of education and may suggest those with higher levels of education are quicker 
at utilizing the cognitive strategies required to process and organize detailed 
medication information. 
  Additionally, although gender demonstrated no significant associations to most 
of the CSMS performance scores, the number of men in some of the subsamples was 
too small to make meaningful comparisons.  This relationship, however, may 
underscore the need to further examine gender effects on this task by utilizing a 
sample with larger proportions of men. 
Relationship of CSMS Performance and GDS Score 
While the group comparisons suggested that more depressive symptoms were 
being reported by those in the MCI group and those in the oldest age groups among 
the intact sample, it is important to note that none of the participants in this study who 
were administered the GDS were classified as clinically depressed according to the 
normative data.  Upon further analysis, some of the CSMS performance scores were 
found to be associated with the GDS Score.  These included the tasks of cued recall, 
dose calculations and dose planning.  Higher scores on the GDS were associated with 
lower scores on the medication tasks involving cued recall, calculational ability and 
planning and organizational ability.     
Of further interest and support of the discriminative construct validity of the 
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processing speed tasks of the CSMS, the arrangement time score demonstrated a weak 
but significant association with the Geriatric Depression Scale score, however the 
study time score did not. Longer arrangement time scores indicating a slower speed of 
processing were associated with higher levels of depression.  Although it was not 
central to the hypotheses of this study, the nature of this relationship is supported in 
some previous research regarding depression and cognitive speed of processing. 
Internal Consistency and Item Difficulty 
  While there are other measures of test reliability which are important to 
examine, this study, because it was conducted using data from a previously exisisting 
database, was limited to examining reliability in terms of internal consistency.  
Because the CSMS was designed as a screening instrument and some of the CSMS 
tasks have very few items, the utility of the examination of this type of reliability for 
the CSMS tasks of dose calculations, clock reading and bottle opening is also limited. 
  Dose Calculations:   In an examination of the reliability of the dose calculation 
task, the internal consistency of the task was found to be rather low, however given 
that there are only two items on this task, this is not an unexpected finding.  Although 
both calculation items were found to be relatively easy for most of the participants in 
the sample to process, calculation item B was found to be a bit more difficult than item 
A.  While calculation A simply involves estimating how many pills are needed for one 
day, calculation B may involve a slightly higher level of calculational complexity in 
that it requires an estimation of how long the medication will last if taken as directed. 
  Clock Reading:  In an examination of the reliability of the clock reading task, 
the internal consistency of the task was found to be rather low.  Given that there are 
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only four items on this task, this is not an unexpected finding.  Analysis of the item 
difficulty index indicated that most clocks were relatively easy to read for these older 
adults, however one clock was identified as being more difficult than the others. 
Further examination of the individual clock item stimulus revealed a visual 
"ambiguity" in the graphic depiction of the clock hand placement which may have 
caused a higher percentage of participants to incorrectly identify the time on that 
clock.  As a result, it is recommended that this item be removed from the scale, unless 
the visual ambiguity can be corrected. 
  Bottle Opening:  The internal consistency was found to be extremely low for the 
bottle opening task.  Again, given the small number of items, this is not an unexpected 
finding.  An analysis of the item difficulty index for the four bottle opening items 
revealed that the two largest items were opened successfully by almost all participants 
and that the small-child resistant container was the most difficult item. This is not 
surprising as some research suggests that older adults may have difficulty with the fine 
motor coordination needed to open the smaller and more "complex" containers, due to 
increased incidence of debilitating physical conditions such as arthritis. 
  While the dose calculation, clock reading and bottle opening tasks did not yield 
adequate levels of internal consistency, it would not be practical to discard the items.  
In this case, it is important to consider the fact that these items are simply part of a 
screening measure and that the low levels of internal consistency are likely a result of 
the very small number of items representing the construct and the relative ease of the 
items comprising those scales. 
  Prospective Memory Item:  It is important to note that the prospective memory 
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instruction item was recalled by all participants regardless of age or cognitive group.  
This suggests that all participants at least, heard the instruction and were able to repeat 
it.  As a result of these findings, the failure of this item could be a pathognomonic 
indicator, suggesting a severe level of cognitive impairment. 
  Recall Tasks:  An examination of the internal consistency of all three of the 
CSMS recall tasks appears to have provided more useful information regarding the 
internal consistency or homogeneity of these scales.  As the recall task scales of the 
CSMS have substantially more items than the other previously mentioned CSMS 
scales, they also showed greater levels of internal consistency.  The levels of internal 
consistency for the immediate and delayed recall tasks of the CSMS were relatively 
adequate while the internal consistency level for the cued recall task was the strongest.  
The nine items on each of the three CSMS recall tasks show adequate levels of 
internal consistency suggesting they are homogenous in nature.  The results of the 
previously described findings of this study and previous pilot studies suggest that the 
three recall tasks of the CSMS comprise homogenous scales of memory ability.   
  Qualitative analysis of the item difficulty indices revealed a similar trend across 
the three recall tasks.  Card 8 ("if rash occurs call doctor") was demonstrated to be the 
easiest information card to recall across all three memory tasks.  Although in varying 
orders among the three memory tasks, cards 4 ("heart medicine"), 2 ("may cause a 
rash") and 5 ("may cause sleepiness") were all demonstrated to be the next 3 easiest 
cards to recall across the immediate, delayed and cued recall tasks.  This pattern may 
support previous research which suggests that healthy older adults organize 
medication information according to semantic or context-specific clusters and that 
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these clusters facilitate recall of medication information.  A research paradigm which 
examines the nature of these clusters and aims to support this hypothesis is currently 
under investigation in another separate study of medication management using the 
CSMS. 
 Strengths and Limitations of the Study 
Generalizability 
  Although the present study may provide relevant information regarding the 
psychometric properties of the various tasks of the CSMS and of the entire measure as 
a comprehensive assessment of medication-taking skills, it is important to note that 
these findings have limited generalizability, based on the specific sample used in this 
research.   
  The results of this study are based upon a sample of independently functioning 
older adults ranging in age from 72 - 95 with limited variability of geographical 
location, gender, ethnicity cognitive status and educational level.  In general, the 
sample consisted of a relatively educated group of older adults all of whom were from 
the greater Philadelphia area.  Diversity of ethnicity and gender was not well 
represented as the sample had a relatively higher proportion of white female 
participants.  Further studies with more adequate representations of participants from 
diverse geographical, ethnic and racial backgrounds as well as a more adequate 
representation of male participants may be necessary to better describe the 
psychometric properties of the CSMS tasks of medication taking. 
  Despite the aforementioned limitations, this is the first study to formally and 
explicitly identify the predominant cognitive and sensory components of medication 
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taking.  It is also the first to formally examine the relevant psychometric properties 
and the factor structure of the Cognitive Screening for Medication Self-Management 
(CSMS). 
Threats to Internal Validity 
  The most obvious threat to internal validity in this study involves the limited 
sample size.  The small sample size reduced the statistical power of the comparative 
analyses and may have compromised the study's ability to detect significant 
differences between the groups.   
  In addition, a revision in the instructions during the data collection regarding the 
arrangement task of the medication cards may have also compromised the internal 
validity of the study.  While some subjects were administered an older version of the 
instructions, others had the newer instructions and this, to some extent, may have 
confounded to some extent, the results of performance on the recall tasks.    A future 
research protocol might examine any potential differences in the instructions and the 
potential influence of this factor on the performance of the recall tasks. 
Conclusions and Future Directions 
  The CSMS appears to assess a comprehensive set of cognitive, visuosensory and 
sensorimotor abilities which are shown to be the most relevant components related to 
medication taking.  The test measures the primary cognitive substrates of medication 
taking with items related to retrospective memory and including tasks of immediate, 
delayed and cued recall in addition to aspects of executive functioning such as 
planning/organizational ability as measured by a dose planning task.  It also includes 
cognitive tasks which assess dosage calculational ability, prospective memory, and 
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processing speed as measured by study time and arrangement time for medication 
information. 
  In addition to the predominant cognitive substrates of medication taking, the 
CSMS also includes a measure of clock reading which is purported to require very 
little effortful cognitive processing, in addition to two non-cognitive tasks which 
assess visuosensory ability/visual acuity as measured by label reading and 
sensorimotor ability as measured by a bottle opening task. 
In addition to providing crucial information regarding the discriminant and 
convergent construct validity of the CSMS scales, the results of the factor structure 
may also have some practical implications for the future scoring of the CSMS.  While 
the CSMS was designed as a screening measure for a heterogeneous variety of 
cognitive and sensory tasks, using one overall score for the test does not appear to be 
practically or psychometrically justified.  Future revisions of the scoring system for 
the CSMS, however, might include development of a number of index scores which 
based on the five identified components.  The most practical of these index scores 
would be a memory and organizational score based on the total scores from the 
memory tasks, the dose planning task and the dose calculation task.  Another useful 
index score would be for processing speed and would comprise the scores for both 
study time and arrangement time.  Although the scores for bottle opening and label 
reading might comprise a sensory index score, further research is needed to best 
determine the utility of that.   
  While this study provides some preliminary evidence to support the construct 
validity of the CSMS as a measure of memory and organizational ability, more studies 
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which further examine other aspects of construct validity should be conducted.  For 
example, cross-validation of the CSMS scores with other previously validated and 
reliable measures of memory, calculational ability, processing speed and executive 
functioning ability may be used to further delineate the specific cognitive substrates of 
the CSMS scales. 
  In addition, while future research studies involving the CSMS may potentially 
aim to identify normative performance for each of the CSMS tasks, studies which seek 
to identify functional capacities or limitations may prove to be more practical for a  
screening measure such as the CSMS.  While normative referenced test scores can 
identify "normal" performance for a specified reference group or population, these 
scores, usually reported as percentiles or standard scores, have little utility in 
identifying the  real-life functional capacity or limitations of the constructs and 
populations under investigation.   Research which identifies functional correlates with 
the CSMS task scores may provide the foundation for a clinical manual which will 
improve the utility of the instrument. 
  As the results of the internal consistency of some of the CSMS scales in this 
study yielded information of marginal relevance, future studies involving other forms 
of reliability of the CSMS will need to be conducted.  Additional reliability studies 
using the CSMS should examine the test-retest-reliability and inter-rater reliability. 
  Since the global dimension of medication adherence involves a number of other 
relevant real-life factors which were not addressed in this study, future research to 
more fully examine the ecological validity of the CSMS should be conducted.  This 
can be accomplished through more research involving a comparison of performance of 
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CSMS tasks with performance on those real-life measures of medication taking.  To 
more fully understand the wide range of issues related to medication adherence, future 
research should also involve examining the relationship of CSMS performance to 
measures which assess other real-life aspects of medication adherence such as 
attitudinal influences. 
  It is also important to note that the CSMS task, although it mimics real-life tasks 
of medication taking, and appears to possess a high degree of face validity or 
ecological verisimilitude, it may not statistically relate very well to real-life 
medication information or to real world medication-taking performance.  In this 
respect, future investigations of the CSMS should involve a verdicality approach to the 
assessment of the ecological validity.  The aim of this approach would be to 
empirically support the relationship of the CSMS scales to measures of real-world 
functioning.  The results of these studies could further support the instrument's 
practical utility in identifying a population's distinct functional capacities and 
limitations as they relate to medication taking tasks and activities.  Studies of this type 
may provide the foundation for the development of specific interventions to help those 
at risk for medication problems to compensate for their limitations. 
  Although some previous research using the CSMS in a schizophrenic population 
has shown promise in the test's ability to predict success in a medication management 
program, future research could improve the predictive validity of the test using other 
populations.  To further explore the discriminative and predictive ability and provide 
further evidence to support the construct validity of the CSMS, future research should 
involve examination of performance of the CSMS among diverse clinical patient 
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populations such as brain injury and those various medical conditions. An examination 
of performance, especially among those in which medication problems might have 
more profound physical or mental consequences, may also prove beneficial. 
  The further development of the CSMS as a theoretically valid and reliable 
measure of medication management will help clinical health care providers to identify 
individuals with medication management difficulties early and possibly prevent 
negative outcomes such as nonadherence and adverse medical effects.  The CSMS 
Clinicians may use results of the CSMS to facilitate the actual development of 
specific, functional intervention strategies in those who are having difficulty taking 
their medications successfully.  It will be easier and much more practical to develop 
compensatory strategies if clinicians know exactly which part of the individual’s 
medication process is impaired.  In addition, although identification of impaired sub-
skills within the medication taking process is important, clinicians will also benefit 
from identification of the cognitive skills which are found to be intact.  The most 
efficient strategies for assisting medication self management are those which could 
capitalize on an individual’s cognitive strengths in the process of helping them 
compensate for those skills which may be impaired. 
An instrument with established normative data and proven levels of high 
ecological validity is likely to have broad clinical applications.  Such an instrument 
may be widely used by practitioners to answer very practical questions about a client’s 
ability to follow their medication routine successfully and to formulate successful 
intervention strategies when they are having difficulties.  In addition, a greater 
understanding of the cognitive and memory difficulties older adults may have will 
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permit more effective cognitive and behavioral interventions and supports. 
With a reliable, valid and widely used assessment tool such as the CSMS, and a 
proactive, focused level of assistance, clinicians may be better able to identify those 
individuals at risk for medication difficulties and to also help those individuals 
manage their medication regimens.  As a result of widespread effective medication 
management in older adults and other populations, long-term benefits to our health 
care system are also likely to be demonstrated.  
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Table 1 
 
Summary of All Participants by Cognitive Group 
                  
INTACT  (n = 46)  MCI   (n = 14) 
 
(MMSE >=27)   (MMSE <27) 
      
    Mean     (SD)     Mean   (SD)    F   (df)     p 
 
 
Age    82.39  (5.10)    86.29    (5.03)    6.30  (1, 58)  < .05  
 
Education *  14.92  (2.60)    13.73    (2.94)    1.77  (1, 53)  ns 
 
MMSE   28.61    (.98)     24.29    (1.94)     126.71  (1, 58)  < .01 
 
GDS**   1.79      (2.38)       4.00     (3.06)      4.70  (1, 44)  < .05 
  
 
      n    %    n   %      x2  (df)     p 
 
 
GENDER                 6.10 (1)   < .05    
                            
Male     8   17.4      7  50 
 
Female    38   82.6      7  50 
 
ETHNICITY                .82  (1)   ns 
 
Caucasian    45     97.8    13  92.9      
 
African American    1      2.2        1    7.1 
 
 
 
*   (intact n = 44; comparison n = 11) 
 
**  (intact n = 39; comparison n = 7) 
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Table 2 
 
Summary of Intact Participants by Age Group 
                  
    Youngest-Old  Old-Old   Oldest-Old 
    (72-79)        (79-84)   (85+) 
 
    (n = 17)        (n = 15)   (n = 14)           
                          Tukey 
    Mean (SD)      Mean (SD)  Mean (SD)  F  (df)  p  Post-Hoc 
 
 
Age   77.41 (1.91)      82.2 (1.42)      88.64 (2.95)  104.3 (2, 43)  < .01 1 < 2 <3 
 
Education * 14.94 (2.41)      15.36 (2.68)        1.42 (2.86)  .425 (2, 41)  ns   
 
MMSE  28.88   (.99)      28.67   (.90)        28.21   (.98)  1.91 (2, 43)  ns 
 
GDS **           .82  (1.02)          2.15 (2.76)         3.11 (3.02)  3.31 (2, 36)  < .05 1 < 3   
  
 
    n       (%)    n     (%)   n     (%)    x2  (df)     p 
 
 
GENDER                   8.6  (2)   < .05 
 
Male      2      (11.8)   6     (40)   
 
Female  15     (88.2)   9     (60)   14     (100) 
 
ETHNICITY                  .31  (2)      ns 
 
Caucasian  17     (100)   15     (100)  13    (92.9) 
 
African 
American                      1      (7.1) 
 
 
 
*   (Old-Old n = 14; Oldest-old  n = 13) 
 
**  (Old-Old n = 13; Oldest-old  n = 19) 
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 Table 3 
 
CSMS Task Score  Means, Standard Deviations and Ranges of Sample 
 
TASK     N   MEAN   (SD)        RANGE 
_____________________________________________________________________ 
 
Immediate    59   6.90   (2.02)    0 - 9 
Recall 
 
Delayed     59   5.20   (2.73)    0 - 9   
Recall 
 
Cued      53   5.79   (2.66)    0 - 9 
Recall 
 
Prospective    59   1.37   (.76)     0 - 2 
Memory 
 
Dose      56   50.52   (8.71)    17 - 56     
Planning 
 
Dose      58   1.52   (.66)     0 - 2  
Calculations 
 
Study     56   65.04   (55.48)    5 - 317 
Time 
 
Arrangement   59   89.63   (50.02)    22 - 255 
Time 
 
Clock     46   3.74   (.54)     2 - 4   
Reading 
 
Bottle     50   2.88   (.33)     2 - 3  
Opening 
 
Label      59   1.97   (1.96)    1 - 9 
Reading 
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Table 4 
 
Eigenvalues, Percentages of Variance, and Cumulative Percentages for Factors of the 
CSMS 
                  
Factor  Eigenvalue  % of Variance   Cumulative % 
    
 
1          4.03         36.65         36.65 
 
2          1.51        13.72          50.37 
 
3         1.21        11.01         61.38 
 
4        1.13        10.31          71.69 
 
5          .77          7.00           78.69  
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Table 5 
 
Summary of CSMS Tasks and Factor Loadings for Varimax Orthogonal Five-Factor 
Solution (N = 60) 
                  
             Factor Loading 
 
          1          2    3       4     5  
 
 
Delayed    .85  -.16  .21  -.01  .04 
Recall 
 
Immediate   .81  -.26  .04  -.01  .02 
Recall 
 
Cued     .81  -.12  .26  -.19  -.07 
Recall 
 
Dose     .76  -.19  -.12  .19  -.21  
Planning 
 
Dose     .73  -.02  -.24  -.09  -.01 
Calculations 
 
Study    -.28  .84  -.02  -.17  -.07 
Time 
 
Arrangement  -.15  .74  .03  .19   .38 
Time 
 
Clock    .17  -.03  .90  .19   .02 
Reading 
 
Prospective   .52  -.11  -.56  .34  -.23 
Memory 
 
Bottle    -.09  -.01  .11  .95   .05 
Opening 
 
Label     -.05  .11  .06  .03   .95 
Reading 
 
 
Note:  Boldface indicates highest factor loadings 
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Table 6 
 
Intercorrelations of CSMS Performance Scores and MMSE Score 
                  
MEASURE      MMSE      n 
 
 
Dose         .68     56 
Planning 
 
Immediate        .58     59    
Recall 
 
Delayed        .48      59 
Recall 
 
Cued          .43     53   
Recall 
 
Study       -.43      56 
Time 
 
Prospective       .38     59  
Memory 
 
Dose         .33     58     
Calculations 
 
Arrangement     -.33      59 
Time 
 
Clock           ns   
Reading 
 
Bottle         ns          
Opening 
 
Label          ns     
Reading 
 
        
 
Note:  All coefficients are one-tailed and significant at p < .01 
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Table 7 
 
Performance Summary of Retrospective Memory, Calculational and Organizational 
Tasks by Cognitive Group 
                  
INTACT       MCI  
 
(MMSE >=27)   (MMSE <27) 
      
    Mean     (SD)     Mean   (SD)    F   (df)     p 
 
 
RETROSPECTIVE 
MEMORY 
 
Immediate  (n = 45)     (n = 14) 
Recall    7.33 (1.77)    5.50  (2.18)    5.57  (2, 58)  < .01 
 
Delayed    (n = 45)     (n = 14) 
Recall    5.71  (2.58)    3.57  (2.65)    4.62  (2, 58)  < .05  
 
Cued     (n = 39)     (n = 14) 
Recall    6.49  (2.44)    3.86  (2.32)    6.04  (2, 52)  < .01    
CALCULATIONAL 
ABILITY 
 
Dose     (n = 46)     (n = 12) 
Calculations  1.59  (.62)     1.25  (.75)     2.47  (2, 57)  .09 
ORGANIZATIONAL 
ABILITY 
 
Dose    (n = 43)     (n = 13) 
Planning   53.58  (4.94)    40.38  (10.83)    18.95  (2, 55)  < .01 
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Table 8 
 
Performance Summary of Processing Speed, Recognition, Sensory-Motor and Visual 
Acuity Tasks by Cognitive Group 
                  
INTACT       MCI  
 
(MMSE >=27)   (MMSE <27) 
      
    Mean     (SD)     Mean   (SD)    F   (df)     p 
 
 
PROCESSING 
SPEED 
 
Arrangement  (n = 45)     (n = 14) 
Time    83.18 (49.35)*   110.36   (48.10)   5.03  (2, 58)  .01 
 
Study     (n = 44)     (n = 12) 
Time    54.45  (35.80)    103.83  (91.06)   4.56  (2, 55)  < .05  
 
RECOGNITION 
 
Prospective   (n = 46)     (n = 13) 
Memory   1.48  (.69)     1.00  (.91)     4.06  (2, 58)  < .05    
Clock    (n = 39)     (n = 7) 
Reading   3.77  (.54)     3.57  (.54)     .436  (2, 45)  ns    
SENSORY- 
MOTOR 
 
Bottle     (n = 39)     (n = 11) 
Opening   2.90  (.31)     2.82  (.41)     .528  (2, 49)  ns 
VISUAL 
ACUITY 
 
Label    (n = 45)     (n = 14) 
Reading   1.84  (1.94)    2.36  (2.02)    5.91  (2, 58)  < .01 
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Table 9  
 
Performance Summary of Retrospective Memory, Calculational and Organizational 
Tasks Among the Intact Participants by Age Group 
                  
    GROUP 1   GROUP 2   GROUP 3 
 
    Youngest-Old  Old-Old   Oldest-Old 
 
    (72-79)        (79-84)   (85+)  
                                
    Mean (SD)      Mean (SD)  Mean (SD)   F    (df)   p     
 
 
RETROSPECTIVE 
MEMORY 
 
Immediate (n = 17)        (n = 15)   (n = 13) 
Recall   7.82  (1.33)  6.60 (2.17)  7.54 (1.61)   2.13   (2, 42)  ns   
 
Delayed  (n = 17)        (n = 15)   (n = 13) 
Recall   6.76  (2.20)  4.80  (3.14)  5.38  (1.94)   2.64 (2, 42)  ns 
 
Cued   (n = 16)        (n = 12)   (n = 11) 
Recall   7.19 (2.26)  5.33  (2.77)  6.73 (2.01)   2.19 (2, 36)  ns 
 
CALCULATIONAL 
ABILITY 
 
Dose     (n = 17)        (n = 15)   (n = 14) 
Calculations  1.76  (.44)   1.60 (.74)   1.36  (.63)   1.73 (2, 43)  ns       
 
ORGANIZATIONAL 
ABILITY 
 
Dose    (n = 17)        (n = 15)   (n = 11) 
Planning     54.47  (4.57)  52.13 (6.46)   54.18  (2.40)  1.00 (2, 40)  ns 
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Table 10 
 
Performance Summary of Processing Speed, Recognition, Sensory-Motor and Visual 
Acuity Tasks Among the Intact Participants by Age Group 
                  
    GROUP 1   GROUP 2   GROUP 3 
 
    Youngest-Old  Old-Old   Oldest-Old 
 
    (72-79)        (79-84)   (85+) 
 
    (n = 17)        (n = 15)   (n = 14)           
                               Tukey 
    Mean (SD)      Mean (SD)  Mean (SD)  F    (df)   p    Post-Hoc 
 
 
PROCESSING 
SPEED 
 
Arrangement  
Time   57.12 (21.73) 102.27 (65.05) 95.23 (42.30)* 4.50   (2, 42)  < .05  1 < 2 
 
Study 
Time    48.65  (33.36)  52.80  (38.40)  64.75  (36.66)** .73  (2, 41)  ns   
 
RECOGNITION 
 
Prospective   
Memory  1.65  (.61)   1.73 (.59)   1.00  (.68)   5.96 (2, 43)  < .01      3 < 1, 2 
 
Clock 
Reading  3.82 (.53)   3.62 (.65)*  3.89  (.33)***  .84  (2, 36)  ns  
 
SENSORY- 
MOTOR 
 
Bottle  
Opening  3.00  (.00)   2.85 (.38) *  2.78  (.44) ***  1.90 (2, 36)  ns 
 
VISUAL 
ACUITY 
 
Label 
Reading  1.35 (1.22)  1.87  (1.60)  2.46  (2.85) *  1.21 (2, 42)  ns   
 
 
 
*      n = 13 
**     n = 12 
***   n = 9 
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Table 11 
 
Summary of Oldest-Old Participants by Cognitive Group 
                  
INTACT  (n = 14)  MCI   (n = 10) 
 
(MMSE >=27)   (MMSE <27) 
      
    Mean     (SD)     Mean   (SD)    F   (df)     p 
 
 
Age    88.64  (2.95)    88.70    (3.30)    .002  (1, 22)    ns 
 
Education *  14.42  (2.86)    14.00    (3.42)     .09  (1, 19)    ns 
 
MMSE   28.21    (.98)     24.60    (2.01)     76.20  (1, 22)  < .01 
 
GDS **     3.11     (3.02)        4.00     (2.45)    .32   (1, 12)    ns 
  
 
      n (%)    n  ( %)      x2  (df)     p 
 
 
GENDER                  11.2 (1)   < .01   
                             
Male             6  (60) 
 
Female    14 (100)      4  (40) 
 
ETHNICITY                 .75  (1)     ns 
 
African American  1    (7.1)          
 
Caucasian       13  (92.9)      10 (100) 
 
 
*   (intact n = 13; comparison n = 8) 
 
**  (intact n = 9; comparison n = 5) 
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Table 12 
 
Performance Summary of Retrospective Memory, Calculational and Organizational 
Tasks by Cognitive Group Among the Oldest - Old 
                  
INTACT       MCI  
 
(MMSE >=27)   (MMSE <27) 
      
    Mean     (SD)     Mean   (SD)    F   (df)     p 
 
 
RETROSPECTIVE 
MEMORY 
 
Immediate  (n = 13)     (n = 10) 
Recall    7.54 (1.61)    5.60 (1.84)    7.24  (1, 21)  < .05 
 
Delayed    (n = 13)     (n = 10) 
Recall    5.38  (1.94)    3.50  (2.76)    3.71  (1, 21)  .07  
 
Cued     (n = 11)     (n = 10) 
Recall    6.73  (2.01)    3.90  (2.38)    8.73  (1, 19)  < .01    
CALCULATIONAL 
ABILITY 
 
Dose     (n = 14)     (n = 8) 
Calculations  1.36  (.63)     1.38  (.74)     .004  (1, 20)  ns 
ORGANIZATIONAL 
ABILITY 
 
Dose    (n = 11)     (n = 10) 
Planning   54.18  (2.40)    41.80  (9.31)    18.22  (1, 19)  < .01 
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Table 13 
 
Performance Summary of Processing Speed, Recognition, Sensory-Motor and Visual 
Acuity Tasks by Cognitive Group Among the Oldest - Old 
                  
INTACT       MCI  
 
(MMSE >=27)   (MMSE <27) 
      
    Mean     (SD)     Mean   (SD)    F   (df)     p 
 
 
PROCESSING 
SPEED 
 
Arrangement  (n = 13)     (n = 10) 
Time    95.23 (42.30)   110.80   (47.02)   .696  (1, 21)  ns 
 
Study     (n = 12)     (n = 8) 
Time    64.75  (36.66)    85.13  (70.46)    .724  (1, 18)  ns  
 
RECOGNITION 
 
Prospective   (n = 14)     (n = 10) 
Memory   1.00  (.68)     1.10  (.99)     .086  (1, 22)  ns    
Clock    (n = 9)      (n = 5) 
Reading   3.89  (.33)     3.60  (.55)     1.54  (1, 12)  ns    
SENSORY- 
MOTOR 
 
Bottle     (n = 9)      (n = 7) 
Opening   2.78  (.44)     2.86  (.38)     .144  (1, 14)  ns 
VISUAL 
ACUITY 
 
Label    (n = 13)     (n = 10) 
Reading   2.46  (2.85)    2.70  (2.26)    .047  (1, 21)  ns 
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 Table 14 
 
Internal Consistency and Item Difficulty Index Values for Clock Reading, Bottle 
Opening and Dose Calculation Tasks 
_____________________________________________________________________ 
                 n   Item       Internal 
         TASK          Difficulty      Consistency 
Index  
_____________________________________________________________________ 
 
Clock Reading     46                .17   
 Clock 4  (4.25)            .98 
 Clock 1  (3:10)         .96   
 Clock 3  (8.55)        .96 
 Clock 2  (7:45)        .80 
Bottle Opening     56                     -.08 
 Medium Screw-Top     1.00  
 Small Flip-Top          .98 
Small Child-Resistant        .89   
Dosage Calculations    59                .31  
 Calculation 1         .81 
 Calculation 2         .68 
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Table 15 
Internal Consistency and Item Difficulty Index Values for Immediate Recall Task  
_____________________________________________________________________ 
                 Item     Internal 
         TASK        Difficulty    Consistency 
 n   Index  
_____________________________________________________________________ 
 
Immediate Recall   55                        .58  
 
Card 8          .85 
(If rash occurs 
call doctor) 
 
Card 4          .83 
(Heart Medicine) 
 
Card 2         .76 
(May cause a rash) 
 
Card 5         .75 
(May cause 
Sleepiness) 
 
Card 7         .73 
(Cardipol) 
 
Card 6         .66 
(2 Pills before 
Breakfast) 
 
Card 9         .60 
(Take for 2 weeks) 
  
Card 3 
(Do not take w/ food)     .58 
  
Card 1 
(2 Pills before bed)        .55 
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Table 16  
 
Internal Consistency and Item Difficulty Index Values for Delayed Recall Task  
_____________________________________________________________________ 
                  Item     Internal 
         TASK       Difficulty    Consistency 
 n   Index  
_____________________________________________________________________ 
 
Delayed Recall       55                      .64  
 
Card 8          .80 
(If rash occurs 
call doctor) 
 
Card 4         .67 
(Heart Medicine) 
 
Card 2       .65 
(May cause a rash) 
 
Card 5         .65 
(May cause 
Sleepiness) 
  
Card 3         .45 
(Do not take w/ food)      
 
Card 9         .43 
(Take for 2 weeks) 
 
Card 7         .33 
(Cardipol) 
 
Card 1         .33 
(2 Pills before bed)      
 
Card 6        .27 
(2 Pills before 
Breakfast) 
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Table 17 
Internal Consistency and Item Difficulty Index Values for Cued Recall Task  
_____________________________________________________________________ 
                Item     Internal 
         TASK       Difficulty    Consistency 
 n   Index  
_____________________________________________________________________ 
 
Cued Recall        48                          .84  
 
Card 8         .81 
(If rash occurs 
call doctor) 
 
Card 2         .73 
(May cause a rash) 
 
Card 4         .71 
(Heart Medicine) 
 
Card 5        .52 
(May cause 
Sleepiness) 
  
Card 9        .42 
(Take for 2 weeks) 
 
Card 1        .42 
(2 Pills before bed) 
      
Card 3        .36 
(Do not take w/ food)      
 
Card 6        .35 
(2 Pills before 
Breakfast) 
 
Card 7        .27 
(Cardipol) 
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